Programme
Sunday, September 20, 2026
-
08:00–15:00
Satellite Program (Pre-congress activities)
-
08:00–13:00
Post-Graduate Course - Clinical Program
-
08:00–13:00
Post-Graduate Course - Fundamental and translational science
-
08:00–13:00
Global nursing and allied health leadership in organ donation and transplantation
Organized by: TTS Allied Health Committee - In Collaboration with
-
08:00–13:00
Pediatric Transplantation
-
08:00–15:00
Transplant Infectious Diseases (TID)
Organized by
In collaboration with
-
08:45–13:00
Women in Transplantation
Organized by:
-
09:00–12:30
TSANZ Research Accelerator Showcase
Organized by:
-
09:00–11:30
How to do controlled and uncontrolled DCD in the world
Introduction DCD future development in pediatricsGabriel E. Gondolesi (US)Introduction of DCD international practicesMarti Manyalich Vidal (ES)Detection and evaluation of DCD donorsMauricio Pereira (ES)Family communication in the context of DCD donationChloë Ballesté Delpierre (ES)Adequation of life sustaining therapy and death declarationSara Alcantara Carmona (ES)Ex-Situ machine perfusionJoaquim Albiol (ES)Ethic & Legal Barriers for NRP and TANRP in DCD worlwideBeatriz Domínguez-Gil (ES)ConclusionMarti Manyalich Vidal (ES)
-
13:30–14:30
From principles to practice: Advancing diversity, equity, and inclusion in transplantation
Supported by:
in partnership with:
Chairs: Nazia Selzner (CA); Cynthia Tsien (CA)
2SLGBTQI-Inclusive care in organ donation and transplantationCarmen Hrymak (CA)Innovations to improve equity and access in pediatric kidney transplantationAviva Goldberg (CA)Mindfulness and meaning in transplant medicine: Supporting the workforceChaya Shwaartz (CA) -
15:00–18:30
Opening Ceremony & Plenary Session
-
15:00–16:30
Opening Ceremony
-
16:45–18:30
Plenary Session 1 (with Starzl and Kanoria Awards)
Early clinical experience with gene-edited porcine kidney xenotransplantation in four living human recipientsLeonardo Riella (US)Validating RenalAgent: An Artificially Intelligent Autonomous Agent for Renal PathologyHarry Robertson (AU)Artificial intelligence in medicineKarin Verspoor (AU)
-
18:30–20:00
Welcome Reception
Monday, September 21, 2026
-
08:00–09:15
Morning Abstract and Concurrent Sessions
-
08:00–08:45
Takeda Corporate Breakfast Symposium on Illuminated constellations: How diverse experiences guide practical CMV
Organized by
-
08:00–09:00
Advancing living donor kidney transplantation - 1
Chairs: Giselle Guerra (US); Philip Andrew Clayton (AU)
Socioeconomic, demographic, and lifestyle factors associated with living kidney donation among individuals exploring the possibility of donatingAllan Massie (US)Establishing an Operational Framework for a Pan-European Kidney Exchange Programme (EURO-KEP)Per Lindner (SE)The impact of continuous matching on compatible pairs in the Australian and New Zealand Kidney Exchange Program (ANZKX)Stella McGinn (AU)Sex and gender as prognostic factors for health outcomes among living kidney donors: A systematic reviewESWARI VILAYUR (AU)Comparison of erector spinae plane block vs quadratus lumborum type ii block for post-operative analgesia in renal transplant donorsSameer Sethi (IN)Impact of compatible pairs in single centre kidney paired donation to increase donor pool: A cohort studySonam Dhingra (IN) -
08:00–09:00
Immunoregulation - T and B cells
Chair: Shane Grey (AU)
Characterisation of organ donor tissue immunopeptidomes reveals targets of alloreactive CD8+ T cellsAKM Muraduzzaman (AU)Immunogenomic landscape of T cell repertoires after human lung transplantation and its clinical significanceJianing Fu (US)Aberrant autoantibody IgG glycosylation seen in Primary Graft Dysfuntion patients modifies complement activation and macrophage activation in-vitroHassan Moussa (US)Aging Attenuates Humoral Allosensitization Through B Cell-Intrinsic AlterationsFriederike Martin (DE) -
08:00–09:00
Metabolic health and kidney transplant outcomes
Chairs: Mads Hornum (DK); Katharine Hegerty (AU)
Predictive value of early continuous glucose monitoring–detected hyperglycaemia for post-transplant diabetes mellitus among non-diabetic kidney transplant recipientsAbhilash Tirkey (IN)SGLT-2i use and risk of mortality and heart failure in kidney transplant recipients with type 2 diabetes.Babak Orandi (US)Frailty and Quality of Life in Long-Term Kidney Transplant Survivors: A Prospective Cohort StudyYoung Jin Yoo (KR)Temporal changes in gut microbiota across different phases after kidney transplantationYunchao Wang (CN)Impact of Changes in Smoking Behavior Before and After Kidney Transplantation on Graft and Cardiovascular Outcomes: A Nationwide Cohort StudySangwan Kim (KR)Safety and effectiveness of bariatric surgery before and after kidney transplantation: A systematic review and meta-analysisTuerhongjiang Tuxun (CN) -
08:00–09:00
Organ preservation 1
Chairs: Gavin Pettigrew (GB); Natasha Rogers (AU)
Efficacy of 10 degrees Celsius static cold storage for warm ischemic kidneys in MHC inbred CLAWN miniature swineAkiyuki Iwamoto (JP)Extended Normothermic Machine Perfusion Supports Functional Preservation and Induces Regeneration in Ex Vivo Porcine LiversZhen Sun (CN)Drone-based transportation of a donor heart using military UAVs during wartime: Experimental feasibility studyBorys Todurov (UA)A multifunctional polymer for organ preservation and graft survival after transplantationLei Fang (CN)Advanced perfusion techniques eliminate outcome gaps between DCD and DBD liver transplantationTiffany Lim (US)Ex Vivo Whole Eye Perfusion SystemVarun Kopparthy (US) -
08:00–09:00
Advancing kidney transplant equity and access: Global, national, and systems-level perspectives in transplantation
Chairs: Dorry Segev (US); Tracey Ying (AU)
A Decade of Progress in Organ Transplantation in India: National Trends and Growth Patterns (2015–2024)Sana Ahuja (IN)Individual and center level determinants of progression from kidney transplant referral to kidney transplantation in the United States: A national EHR studyMichal Mankowski (US)Predictors of brain death in computed tomography reports in a Portuguese cohort from 2011 to 2024Antonio Gomes (PT)Successful adoption of an electronic donor record management platform for organ and tissue donors across AustraliaChristian Rivas (US)Demographic and Clinical Profile of Active Patients on the Kidney Transplant Waiting List in Saudi Arabia: A 2025 National AnalysisJamail Ghafwari (SA)Thailand’s first national program for deceased organ donor detection: Closing the gap through early identificationKorntip Phonphok (TH) -
08:00–09:00
Personalizing immunosuppression in liver transplantation: From microbiome to malignancy
Chair: Ashwin Rammohan (IN)
-
08:00–09:00
Acute-on-chronic liver failure and liver transplantation: From mechanisms to clinical futility
Chairs: Dinesh Jothimani (IN); Jongman Kim (KR)
Persistent dysregulation of bile acid metabolism after liver transplantation: a longitudinal metabolomic analysisAnna Posthumus (NL)Pre-Transplant Kidney Vulnerability: An Independent Predictor of Major Adverse Kidney Events Following Liver TransplantationBhavin Modasia (IN)Targeting the ELF1-HGFAC axis via Normothermic Machine Perfusion (NMP) rescues regenerative capacity in human Acute-on-Chronic Liver FailureMeiting Qin (CN)Timely Living Donor Liver Transplantation (LDLT) is a lifeline for patients with Acute on Chronic Liver Failure (ACLF) – An experience from a high volume center in AsiaNavin Marannan (IN) -
08:00–09:00
Vasculopathy: A tale of three organs
What we know and don't but should about cardiac allograft vasculopathyKavitha Muthiah (AU)What should we continue to learn from renal allograft pathologyMariam Alexander (US)
-
08:00–09:00
Advancing heart transplantation: Preservation strategies, immune monitoring, and rejection mechanisms
Chairs: Peter MacDonald (AU); Anne Dipchand (CA)
Australian outcomes for hypothermic machine perfusion in heart transplant recipients since 2021: A retrospective, single centre studyNatasha Dehghani (AU)Does significant tricuspid regurgitation early after heart transplantation resolve?Sakae Takenaka (US)Long term rejection outcomes in donation after circulatory death heart transplantationKatherine Wang (AU) -
08:00–09:00
Surgical innovation and technical advances in transplantation
Chairs: Peter G. Stock (US); Dieter Broering (SA)
From niche to multidisciplinary application: advancing non‑vascularized rectus fascia as an innovative allograft in a single-center prospective cohortEwout Muylle (BE)A Retrospective analysis assessing post-operative outcomes in patients with multiple renal vessels undergoing Robotic versus Open Renal Allograft TransplantShaunak Mitra (IN)Safety and Outcomes of External Biliary Drainage in Living-Donor Liver Transplantation: Report of a Prematurely Terminated Randomized Controlled TrialSu young Hong (KR)Largest Single-Center Experience of Robot-Assisted Kidney Transplantation: Outcome AnalysisMohammad Sherwani (IN) -
08:00–09:00
Local/Regional insights for global organ donation advancement
Chairs: Gabriel E. Gondolesi (US); Chloë Ballesté Delpierre (ES)
Latin AmericaGustavo Fernandes Ferreira (BR)EuropeMarti Manyalich Vidal (ES)Middle-East - North AfricaRiadh Fadhil (QA)AsiaSusumu Eguchi (JP)OceaniaHelen Opdam (AU)North AmericaAtul Humar (CA) -
08:00–09:00
Cell-based immunomodulation and transplant tolerance: From mechanisms to long-term outcomes
Chair: Antiopi Varelias (AU)
HLA-Silenced Cell Therapy Enhances Donor Lung Recovery and Mitigates Primary Graft Dysfunction in a Porcine Transplant ModelFranziska Olm (SE)Bioengineered cell therapy platform for allogeneic cell transplant toleranceCorrine Ying Xuan Chua (US)Gene Editing with a Novel Binary Retroviral Vector System to Reduce HLA Class I AllogenicityKatrin Hacke (US)Pramlintide‑expressing stem cell‑derived beta cells limit islet amyloid in a transplantation model of type 1 diabetesSaumadritaa Kar (CA)10-year malignancy outcomes following autologous polyclonal ex-vivo-expanded Treg therapy in renal transplantationAudrey Au Yong (GB) -
08:00–09:00
Pediatric kidney
Chair: Tom Blydt-Hansen (CA)
A novel image-guided size-matching strategy enables living-donor kidney transplantation in very small pediatric recipientsJohan Nordström (SE)Potential neonatal deceased donors after neurological and circulatory determination of death: a National Registry-Based Cohort StudyRebecca Barzegar (AU)Understanding why parents say yes or no to organ donation when their child dies: a mixed method studyLeah McLaughlin (GB)Sex-specific associations of HDL cholesterol with atherosclerosis in pediatric chronic kidney diseaseArshi Choudhary (DE) -
09:15–10:30
Plenary and Concurrent Sessions
-
09:15–10:30
Plenary Session 2 on Making Xenotransplantation Work for Humanity!
Chairs: Peter Cowan (AU); Macey L. Levan (US)
Clinical xenotransplantation: Experience to dateTatsuo Kawai (US)Xenozoonosis, no worries!Anoma Nellore (US)Let’s start with hearts (or lungs?)!Richard N. Pierson (US)Let’s start with islets!Wayne J. Hawthorne (AU)The ethics of new technology in xenotransplantationLuz Padilla (US)Panel DiscussionDiscussion Period (AU) -
09:15–10:30
Beyond survival: Addressing mental health in transplantation
Chairs: Lisa A. Coscia (US); Geoffrey McCaughan (AU)
Why survival alone is not sufficient for transplant successsMariel Nöhre (DE)Psychological distress across the transplant journeyIris Fontanilla (NZ)Practical strategies for integrating mental health in transplant careMing Hwei Yek (US)Panel DiscussionDiscussion Period (AU) -
09:15–10:30
Dedicated donor care units: Centralized donor transfer and outcome optimization
Chairs: David Thomson (ZA); Dale Gardiner (GB)
25 years of innovation: The St. Louis donor care unitGary F. Marklin (US)The US donor care unit landscapeJennifer Prinz (US)The first comprehensive-DCU developed in China leading the change of the procurement modelXuyong Sun (CN)Panel DiscussionDiscussion Period (AU) -
10:30–11:00
Coffee Break / Exhibits and Poster Viewing
-
10:30–11:00
Coffee Break
-
11:00–12:00
Abstract and Concurrent Sessions
-
11:00–12:00
Advancing living donor kidney transplantation - 2
Chairs: Elias David-Neto (BR); Craig Coorey (AU)
Kidney failure after living kidney donation in Australia: A national registry linkage study 2004-2023Melanie Wyld (AU)Mapping the Landscape of European Kidney Exchange Programmes: A Comparative Analysis of Operational and Immunological FrameworksPer Lindner (SE)How a single center achieved a 26% living donor kidney transplant rate through kidney paired donation in IndiaKhushboo Saxena (IN)Renal outcomes in living kidney donors with impaired fasting glucose: A retrospective cohort studyYin Saifu (CN)Health-related quality of life and psychosocial outcomes after living kidney donation in RwandaEmmanuel Muhawenimana (RW) -
11:00–12:00
Infection and biomarkers
Chair: Megan Levings (CA)
Standard-of-Care-Informed Unsupervised Learning and Multi-Biomarker Modeling for Diagnosis of Kidney Transplant RejectionAkhil Singla (US)Spatial and Temporal Dynamics of REG3A as a Biomarker of Intestinal Allograft Health and RejectionDouglas Farmer (US)Comparative Perioperative Kinetics of NGAL and Cystatin C in Predicting Acute Kidney Injury After Liver TransplantationBhavin Modasia (IN)Torque teno virus viral load as a biomarker of rejection, opportunistic infection, and infection recovery during the first six months post kidney transplantationRamyangshu Chakraborty (GB)CMV-DNA Level in zero-hour kidney tissue is associated with Risk of post-transplant CMV Infection in D+/R− Living Donor Kidney TransplantationTakehiro Ohyama (JP)Multidimensional donor–recipient HLA genetic features in relation to post-liver transplant infection riskMingyue Li (CN)Circ-MAPK4 promotes pyroptosis-associated liver fibrosis by regulating the miR-125a-3p–NLRP3 inflammasome axisChao Wang (CN)Host and pathogen pharmacogenetics in Pneumocystis jirovecii pneumonia after kidney transplantation: a retrospective cohort and case–control studyDirk Kuypers (BE)Impact of Cytomegalovirus Infection on IgG Glycosylation in Kidney Transplant RecipientsMarta Crespo Barrio (ES) -
11:00–12:00
Risk determinants for kidney transplant outcomes
Chairs: Madhav Menon (US); Gustavo Fernandes Ferreira (BR)
Patient and graft survival in kidney transplant recipients with lupus nephritis: an ANZDATA registry analysisJacqueline Evans (AU)Donor-Derived Cell-Free DNA at Biopsy Predicts Long-Term Renal Allograft Functional Decline Beyond Histologic Diagnosis: A Prospective Single-Center StudyEunjeong Kwon (KR)Age-interactions and death-censored graft survival - A collaborative study (CTS) reportChristian Unterrainer (DE)Treatment outcomes and allograft survival in kidney transplant recipient with tertiary hyperparathyroidismAnant Pilawan (IN)Acute Rejection in Older Kidney Transplant Recipients: Temporal trends and long-term outcomesTracey Ying (AU) -
11:00–12:00
Immunoregulation 1
Chairs: Anita Chong (US); Maria-Luisa Alegre (US)
Selective loss of donor specific IFNγ regulation and B cell subset remodeling precede de novo donor specific antibody formation in kidney transplantationSumoyee Basu (GB)CAR-Tregs synergize with anti-thymocyte globulin and rapamycin to delay skin allograft rejection.Manjurul Haque (CA)Investigating the role of kidney-resident natural killer cells in the control of human cytomegalovirus within the renal allograftHarry Persaud (GB)Highly Reactive Paternal Alloreactive Memory B Cells Defined by HLA Antibody Profiling of Polyclonal Culture Supernatants in female kidney transplant recipientsMarta Crespo Barrio (ES)Multi-Omic Mendelian Randomization and Experimental Validation Identify NDUFA13 as a Mitochondrial Regulator in Renal Allograft FibrosisQinghuan Shen (CN) -
11:00–12:00
Artificial intelligence and machine learning in transplantation: From pathology to predictive clinical decision support
Chairs: Matthew Sypek (AU); Harry Robertson (AU)
DeepSeek in kidney transplantation: Benchmarking and multi-center evaluation for patient education and clinical decision supportRunmin Ding (CN)Leveraging large languagemodels for systematic thematic analysis in transplant research: Comparative findings across two qualitative studiesCarolyn Sidoti (US)Machine Learning Enhances Traditional Risk Scores for 1‑Year Mortality and Primary Graft Dysfunction in Heart Transplantation: A Surgery‑Centered AI ApproachSarah Fatukasi (NG) -
11:00–12:00
Intestinal transplantation
Chairs: Tomoaki Kato (US); Yaron Avitzur (CA)
Machine perfusion strategies in intestinal transplantation: HOPE outperforms normothermic, subnormothermic and static preservation in an experimental modelJavier Serradilla (ES)Comparison of Hypothermic Oxygenated and Normothermic Machine Perfusion of Human Small Intestine for TransplantationKoki Takase (US)Living Donor Intestinal Transplantation: A Two-Decade Analysis of Recipient and Donor OutcomesGuosheng Wu (CN)Intestinal Transplantation for Pseudomyxoma Peritonei: Outcomes from a Collaborative Peritoneal Malignancy and Transplant ProgrammeHelen Stark (GB)Can Pre-operative Factors Predict Outcomes in Intestinal Transplantation for Pseudomyxoma Peritonei?Charlotte Yates (GB)Donor outcome in living-donor intestinal transplantationFang Kuan Chiou (SG) -
11:00–12:00
DCD: Controlled and uncontrolled—Where are we going?
Chairs: Kenneth J. Woodside (US); Mauricio Pereira (ES)
Potential donors: Controlled and un-ControlledMarti Manyalich Vidal (ES)Role of ICU physiciansSara Alcantara Carmona (ES)Ethics for DCD: How to advance?David Thomson (ZA)Who should Canulate?Lilia Martinez de la Maza (SE)Question PeriodDiscussion Period (AU) -
11:00–12:00
Transplant oncology in HCC and cholangiocarcinoma
Chairs: Julie Heimbach (US); Sudha Kodali (US)
A Retinoid Metabolism–MIF Axis Drives Immune Evasion of Circulating Tumor Cells in Hepatocellular CarcinomaRuilin Cai (CN)Machine perfusion and hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysisPatricia Viana (BR)A Donor Risk Factor Inclusive Advanced Machine Learning Equation For Predicting Cholangiocarcinoma Recurrence After Liver TransplantationLaura Batista de Oliveira (US) -
11:00–12:00
Patient-centered outcomes and psychosocial determinants in kidney transplantation: From digital health to life course impacts
Pilot randomised controlled trial of Advanced Recovery Room care post living donor kidney transplantationKarthik Venkataraman (AU)Impact of the TxMobile app on health related quality of life in transplant recipients assessed by SF thirty six questionnaire pre post intervention analysisAngelika Rzepka (AT)Graft outcomes following pregnancy with a functioning kidney transplant in Australia and New ZealandSu Jen Chua (AU)Identifying research priorities in kidney transplantation: a priority setting partnership with patients, caregivers and healthcare professionals.Nicole Jane Scholes-Robertson (AU)Mental illness and access to kidney transplantation in universal healthcare systems: a multi-national population-based cohort studyJames Hedley (AU)A national cross-sectional study exploring acceptability and attitudinal domains towards patient-led acute rejection surveillance in liver transplantationOmar Quidwai (IE)Research on the psychological motivations and social recognition of organ donors' familiesYajie MA (CN)Burnout in transplant professionals: State of the art and call to actionVanessa Silva e Silva (CA)
-
11:00–12:00
Organ donation pathways and practices
Chairs: Maria Gomez (AE); Tina Coco (AU)
Trusted faces, stronger voices: community-driven engagement can drive organ donationGail Moloney (AU)The Development of Nursing Service System for Organ and Eye Donation Patients at Udon Thani HospitalSasipin Mongkolchai (TH)Towards a Simpler Consent Conversation, Is it Achievable?Olive McGowan (GB)The Resuscitation Paradox: Why Potential Donors do not translate into Organ Donors in IndiaSunil Shroff (IN)Impact of structured national quality audits on deceased donor hospital performance: A three‑year comparison across 2023–2025Tanvi Agarwal (AE) -
11:00–12:00
The -omic era in allograft pathology
Chairs: Nancy Kwan Man (HK); Joshua Lawrence Lee (AU)
Does metabolic phenotype in the kidney affect transplant outcome?Ana Konvalinka (CA)What metabolic interactions drives fibrosis and repair in organ transplantation?Ton J. Rabelink (NL)Endogenous peptides in T cell allorecognition and beyond – Lessons from preclinical modelsAlexandra Sharland (AU) -
11:00–12:00
Transplantation journals: Updates and opportunities
Chairs: Stefan Tullius (US); Fadi Issa (GB)
Structure, achievements, goals – Getting your work published, recognized and highlightedStefan Tullius (US)Transplant-Direct: The online campaign journal with an own agendaEdward Geissler (DE)AI and publishing: When, how and what is legit?Germaine Wong (AU) -
11:00–12:00
Complex multi-organ transplantation: Outcomes, innovation, and allocation challenges
Chair: Thomas Loudovaris (AU)
Delayed bleeding after simultaneous pancreas and kidney transplantation – A systematic review and single-centre experienceZekun Chen (AU)Eplet Mismatching as a Predictor of Acute Rejection in Simultaneous Pancreas Kidney TransplantationXiangyu Lan (CN)Pregnancy outcomes after simultaneous pancreas–kidney transplantation: A single-center cohort studyLucas Garcias (AR)A Novel Hybrid Approach to Simultaneous Pancreas–Kidney Transplantation: Favorable Early OutcomesElif Kortan (US)Paired Kidney Analysis of SHK vs KAT: Modest but Meaningful Gain in Dialysis-Free Survival With Kidney-Alone AllocationSomaya Zahran (US)Dialysis-free survival and graft outcomes after simultaneous pancreas-kidney versus kidney-alone transplantation from the same donor: a national donor-matched analysisOscar Garcia Valencia (US) -
11:00–12:00
Normothermic machine perfusion: Organ assessment, repair, and real-time viability in transplantation
Chairs: Ahmer Mohammad Hameed (AU); Anji Wall (US)
The “sickest first” principle in the machine perfusion liver transplant eraVrishketan Sethi (US)The Use of a Centralized Normothermic Preservation and Assessment Center to Rescue Kidneys Declined after Standard AllocationChris Jaynes (US)Preliminary Results from SAFE-NMP Study: Safety Assessment for Extended Normothermic Machine Perfusion in Deceased Donor Kidney Transplantation- A Single Centre Pilot StudyDevprakash Choudhary (IN)Normothermic Machine Perfusion in En Bloc Kidney Transplantation from Infant Donors: Two Innovative Surgical Approaches and Superior Clinical EfficacyShuangjin Yu (CN) -
12:00–13:30
Lunch Break / Industry Symposia / Lunch with Experts & Mentors
-
12:15–13:15
Hansa BioPharma Corporate Lunch Symposium on Transplanting the untransplantable – Idefirix® (imlifidase), a breakthrough innovation for highly sensitised kidney transplantation
Organized by
-
12:30–13:15
Lunch and Learn Roundtable
CMV GuidelineAtul Humar (CA)Medical Assist in Dying (MAID) and benefit to organ donationMatthew Weiss (CA)Survival outcome impact related to distance from transplant centerSusumu Eguchi (JP)Pediatric cardiovascular health and patient survivalAnette Melk (DE)Induction and mechanisms of transplant toleranceXunrong Luo (US)Alternative islet transplant sitesToby Coates (AU)Transplant policy, development and education to improve access and quality of kidney transplantation across Latin AmericaPaola Karina Garcia Padilla (CO)Roundtable MentorGabriel E. Gondolesi (US)Roundtable MentorHelen Opdam (AU)Roundtable MentorDorry Segev (US)Roundtable MentorSiah Kim (AU)Roundtable MentorFadi Issa (GB)Immunological monitoring of the pancreas graftPablo Uva (AR)
-
13:30–15:00
SOTA, Thematic and Concurrent Sessions
-
13:30–15:00
Precision Immune Engineering in Kidney Transplantation
Chairs: Fadi Issa (GB); Stephen Alexander (AU)
Next-generation co-stimulation blockadeCheng Yang (CN)Regulatory T-cell therapy 2.0: CAR-TregsMegan Levings (CA)Emerging pharmacotherapies for desensitization in HLA incompatible kidney transplantationMarta Crespo Barrio (ES) -
13:30–15:00
Bridging Systems, Scaling Access: Asia-Pacific Leadership in Transplantation
Chairs: Riadh Fadhil (QA); Anil Kumar (IN)
Equity and access in fragile health systems: A south asian perspectiveDibya Singh Shah (NP) -
13:30–15:00
Senotherapy in transplantation
Chairs: Krista Lentine (US); Jasper Iske (DE)
Global and local consequences of ‘environmental sciences’ on organ ageStefan Tullius (US)Cell-type and sex specific aspects of senescenceAnette Melk (DE)Aged immune systems drives organ agingMatthew Yousefzadeh (US)Strategies for senolytic drug discoveryAaron Schindeler (AU) -
13:30–15:00
How to combat transplant tourism
Chairs: Thomas F. Müller (CH); Benita Padilla (PH)
Patients traveling overseas for transplants - Practical experiencesAnantharaman Vathsala (SG)Challenges in registering unethical travel for transplant activitiesDominique Martin (AU)The living donor liver registryDimitri A. Raptis (SA)Tools to detect and report suspicious cases of traffickingMaria Amalia Matamoros (CR)Duty to report – The implementation of mandatory reporting: The UK experience so farJessica Porter (GB)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Bridging Transplantation and Regenerative Medicine: Enhancing Graft Viability and Exploring Stem Cell-Islet Immunotherapies in Diabetes
Chairs: Ahmer Mohammad Hameed (AU); Thomas Kay (AU)
Pancreas transplantation in type 2 diabetes mellitusPeter G. Stock (US)Diagnosis and treatment of pancreas rejectionPablo Uva (AR)Islets and stem cells in diabetes therapy: Current statusEelco de Koning (NL) -
13:30–15:00
The mentorship mosaic: Fostering growth in transplant training and practice
Chairs: Sarah Tsou (US); Natasha Rogers (AU)
Introduction and framing / Panel discussantFadi Lakkis (US)Introduction and framing / Panel discussantR. Cutler Quillin (US)Panel discussantFriederike Martin (DE)Panel discussantGomathy Narasimhan (IN)Panel discussantKhushboo Saxena (IN) -
13:30–15:00
Minimal Invasive Transplantation
Chairs: Susumu Eguchi (JP); Emily Granger (AU)
Minimally invasive thoracic organ transplantationAlbert Jauregui (ES)Minimally invasive abdominal organ transplantationKwang Woong Lee (KR)Education and training strategies to safely disseminate robotic organ transplantationJinna Yao (AU)Future technological development in robotic organ transplantationDieter Broering (SA) -
13:30–15:00
Using Technology to optimize outcomes of Liver Transplantation
Chairs: Shantanu Bhattacharya (AU); Varvara Kirchner (US)
What does optimal use of HOPE and NMP look like?Carlo Pulitano (AU)Ischemia-free organ transplantationZhiyong Guo (CN)The future for artificial Intelligence in liver transplantDorry Segev (US) -
13:30–15:00
Advancing Uterus Transplantation: Global Practices, Innovations, and Program Development
Chairs: Jiri Fronek (CZ); Limor Meoded Danon (IL)
Global uterus transplantation activities and outcomes: the ISUTx registryMats Brännström (SE)Robotic surgery in uterus transplantationJean-Marc Ayoubi (FR)Setting up a uterus transplantation programRebecca Deans (AU)Updates on treatment and donor/recipient selectionPaige Porrett (US) -
13:30–15:00
Innovating the Pathway: Allied Health Contributions to Advancing Organ Donation and Transplantation
Chairs: Anne Floden (SE); Bronwyn Levvey (AU)
Driving excellence in transplant care: The role, vision and impact of the tts allied health committeeEstephan Arredondo (ES)Extending organ viability: The role of allied health in machine perfusion programsJoaquim Albiol (ES)Strategies to improve adherence after solid organ transplantationMariel Nöhre (DE)Panel discussionBronwyn Levvey (AU)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Donor Evaluation and Optimization: Bridging Safety and Organ Utilization
Chairs: Tina Marinelli (AU); Atul Humar (CA)
mNGS and rapid diagnostics: The next frontier in donor screening?Maricar Malinis (US)HIV-positive organ donation: Evolving guidelines and global perspectivesCameron Wolfe (US)MDRO: Cross-disciplinary approaches to donor-derived infection risk assessmentPriscilla Rupali (IN)Donors in the tropics and LMICs: What to consider?Siriorn Watcharananan (TH) -
13:30–15:00
Building high-performing transplant registries: Global consensus recommendations and a practical maturity framework
Chair: Sang Joseph Kim (CA)
Opening remarks and overview: From fragmented data to global alignment. Why transplant registries need a shared frameworkSang Joseph Kim (CA)Creating a transplant registry: Defining purpose, scope, and sustainable infrastructureGermaine Wong (AU)Establishing trust: Governance, ethics, and legal architecture of transplant registriesAxel Rahmel (DE)Designing registries that work: Data architecture, harmonization, and operational feasibilityJon Snyder (US)Using registry data responsibly: Methodology, bias mitigation, and meaningful interpretationAllan Massie (US)From aspirational standards to practical assessment: Introducing the transplant registry maturity modelYee Lu (US)Panel DiscussionDiscussion Period (AU)PanelistNicole Jane Scholes-Robertson (AU) -
13:30–15:00
Harnessing the Power of Genetics in Pediatric Transplantation
Chairs: Siah Kim (AU); Carl Grabitz (DE)
Overview of genomic sequencing techniquesKatherine E. Twombley (US)When and why to consider genetic testing pre-transplantHugh McCarthy (AU)Bioethics in transplant gene testingAnne Priesz (AU) -
15:00–15:30
Coffee Break / Exhibits and Poster Viewing
-
15:00–15:30
Coffee Break
-
15:30–16:30
Afternoon Abstract and Concurrent Sessions
-
15:30–16:30
Transplant candidate determinants of post-transplant outcomes
Chairs: Steve Chadban (AU); Sadia Jahan (AU)
It’s about time: A target trial emulation of preemptive vs. non-preemptive kidney transplantationSang Joseph Kim (CA)Mental Illness and Post-Transplant Outcomes in Kidney Transplant Recipients: A Population-Based Cohort StudyMelanie Wyld (AU)CARSK trial baseline characteristics and generalisabilitySteve Chadban (AU)Targeted Resistance-Based Muscle Therapy in Advanced CKD: Effects on Frailty, Depressive Symptoms, Patient Activation, and Transplant ReadinessElif Kortan (US)Age-dependent differences in pediatric versus adult kidney transplantation: Impaired VEGF and NO signaling weaken microvascular integrity and threaten renal graft survivalAlev Ok Atılgan (TR)Patterns and trends in kidney transplantation among women in adult nephrology practiceNishtha Manuja (IN) -
15:30–16:30
Omics in transplantation 1
Chair: Ana Konvalinka (CA)
Donor PANX1 orchestrates spatiotemporal immune–metabolic defence against MRSA after liver transplantationYiran Xu (CN)Lipid-associated macrophage polarization and APOE–SDC2 signaling underlies chronic xenograft fibrosisMinhee Seong (KR)Quantitative Urine Proteomics Distinguishes Kidney Transplant Rejection from Normal Allograft PathologyStephanie Kuo (AU)Fatty donor liver transplantation reshapes early immune recovery through neutrophil and macrophage reprogrammingYiran Xu (CN) -
15:30–16:30
Cancer, co-morbidities and kidney transplant outcomes
Chairs: Angela Webster (AU); Wai Lim (AU)
Transplantation and mortality as competing outcomes among patients on dialysis with newly diagnosed cancer – a longitudinal cohort study.Ryan Gately (AU)Expanding the Donor Pool: Multicentric Outcomes of Kidney Transplantation from Donors with Small Renal Tumors A Collaborative Study Across Seven European CentersMireia Musquera (ES)Cancer screening participation in solid organ transplant recipients: a scoping reviewNida Saleem (AU)Renal artery embolization to enable transplantation in Polycystic kidney disease: A UK tertiary centre experienceAdithi Shankar (GB)Cancer stage and treatment patterns in kidney transplant recipients compared with non-transplant patients in a multicenter hospital tumor registryLaia Oliveras (ES)Post-Transplant Anemia and Graft Outcomes in 9,472 Kidney Transplant Recipients: Graft Loss Risk Is Amplified at Preserved Renal Functionminyu kang (KR) -
15:30–16:30
Insights into old and new therapeutics 1
Senolytic treatment during normothermic machine perfusion dampens ischemia reperfusion injury in old liversJasper Iske (DE)IgA Specific TCR Engineered T Cells as a Precision Cellular Therapy for IgA-Mediated Kidney Disease in TransplantationMerve Bilici (GB)TESP-0401 improves delayed graft function in a kidney transplantation mouse modelNicola Giacche' (IT)Functional Investigation of Induced Tregs Generated via Locus-Specific Epigenome Reprogramming of Effector T CellsAudrey Au Yong (GB)Strigolactone Analog 13a Prolongs Allograft Survival by Modulating T-Cell Differentiation and Promoting ApoptosisChen Feng (CN)Pre-sensitization disrupts transplant tolerance by driving PD1⁺ regulatory T cells with impaired function in an inflammatory microenvironment.Qiang Zhang (CN)
-
15:30–16:30
Advancing ABO histocompatibility: Needs and solutions
Chair: Janette Kwok (HK)
ABO antigens and antibodies: Updating old dogmasAnne Halpin (CA)Beyond HLA: Adaptive sequencing for blood group profiling in transplantationKaren Sherwood (CA)ABO incompatible kidney transplantation, strategies and successesMarta Crespo Barrio (ES) -
15:30–16:30
Surgical innovation and complex vascular reconstruction in liver transplantation
Chairs: Refaat Kamel (EG); Michael Fink (AU)
Learning-Curve Analysis of Robotic Recipient Liver TransplantationDieter Broering (SA)Deep Learning-Based Quantitative Intraoperative ICG Fluorescence Analysis Predicts Biliary Stricture After Living Donor Liver TransplantationYUYOUNG OH (KR)Comparative Effectiveness of Technical Variants in Pediatric Liver Transplantation: A Network Meta-AnalysisIsabella Faria (US)Is remnant liver volume <30% an absolute contraindication in purely laparoscopic living donor hepatectomy?Sukmin Gwon (KR)The use of a modified great saphenous vein for hepatic vein reconstruction in right lobe living donor liver transplantationBolatbek Baimakhanov (KZ)Synthetic Vascular Grafts for Middle Hepatic Vein Tributary Reconstruction Enhance Liver Regeneration in Right Lobe Living Donor Liver TransplantationHidenobu Kojima (JP)Estimation of whole and left lateral segment volume using donor weight in paediatric liver transplant - how accurate do we get?Mansha Jiwane (AU) -
15:30–16:30
Expanding donor access: The impact of ECMO in thoracic transplantation a TTS/ISHLT Conjunct Session
Chairs: Pablo Sanchez (US); Raj Ramanan (US)
ECPR-driven growth in the donor poolAlvaro Perazzo (BR)Diagnosing brain death in the ECMO patientKavitha Muthiah (AU)The role of NRP and machine perfusion in cardiothoracic transplantationSandra Lindstedt Ingemansson (SE)Complex decisions: Ethical dilemmas of ECMO, DCD and NRP donorsEmily Granger (AU) -
15:30–17:00
From patient to planet: The global essential standards as a framework for transformative change in transplantation
Chair: John J. Fung (US)
The human face of standardsJohn J. Fung (US)Dignity for all: The human covenant: How the global essential standards protect every individual in the transplant encounterEfstratios (Stratos) Chatzixiros (CH)The institutional blueprint: How the global essential standards create a transplant ecosystem that is equitable, safe, and self-sustainingMedhat Askar (QA)Stakeholders perspective from China: Translating standards into value for every actor in the ecosystemHaibo Wang (CN)Stakeholders perspective from Australia: Translating standards into value for every actor in the ecosystemHelen Opdam (AU)Connecting the circles: Panel discussionsDiscussion Period (AU)PanelistKaren Rockell (GB) -
15:30–16:30
Tumor biology and immunotherapy in liver transplantation for hepatocellular carcinoma
Chairs: Nancy Kwan Man (HK); Takashi Ito (JP)
Characterization of CCR8+ Regulatory T Cells as a Key Driver of Tumor Recurrence After Liver Transplantation for Hepatocellular CarcinomaRuidong Ding (CN)Tumor-lysate pulsed dendritic cell as a supplement treatment for post-transplant hepatocellular carcinoma recurrenceWei-Chen Lee (TW)Downstaging strategies for HCC within the AFP score allocation system: a tale of two trajectoriesCatherine Lamarque (FR)Liver-lung communication of cirrhosis-derived CHI3L1 drives hepatocellular carcinoma metastasis after liver transplantationHuigang Li (CN) -
15:30–16:30
Ethical and legal lenses of organ donation and allocation
Chairs: Vasanthi Ramesh (IN); Dominique Martin (AU)
Legal, ethical and logistic challenges during prolonged somatic support of a pregnant woman after neurologic determination of deathMatthew Weiss (CA)A Bolder and Braver approach to deceased organ donation in the UKDale Gardiner (GB)Factors contributing to allocation out-of-sequence for kidneys and livers in the United StatesCarrie Thiessen (US)Professional ethical reasoning in nursing during the DCD process: A comparative study from Sweden and SpainAnne Floden (SE)From Framework to Practice: Implementing Ethical Safeguards for Donation after Assisted Dying in Aotearoa New ZealandKim Grayson (NZ)The 5th Pou (Pillar): Embedding Te Tiriti (Treaty of Waitangi) in Assisted Dying and Donation — An Evolving Approach in Aotearoa New ZealandKim Grayson (NZ)Knowledge Gaps and Ethical Attitudes Toward Organ Donation Among Adolescents in Nepal’s “Kidney Valley”: A Cross-Sectional Survey among High School StudentsPradez Sapkota (NP) -
15:30–16:30
Quality and safety in organ donation and transplant care
Chairs: Lisa A. Coscia (US); Helen L. Pilmore (NZ)
Prioritisation of kidney transplant systematic review and guideline topics: a modified Delphi studyDavid Tunnicliffe (AU)The HOUSES Index directly predicts cumulative hospitalization risk after kidney transplantation.Samy Riad (US)Integrating palliative and supportive care in heart and lung transplantation: phase 1 of a quality improvement initiative for a hybrid service modelShampa Sinha (AU)Organ donation after medical assistance in dying: Evidence on transplant outcomes and system impactAmina Silva (CA) -
15:30–17:00
Infectious complications in solid organ transplantation
Chairs: Matthew Roberts (AU); Stephanie M. Pouch (US)
Integrating Clinical and immune response Biomarkers to Understand kidney Graft recipient’s risk of infection (the IC-BUG study)Matthew Rowlandson (AU)From exclusion to opportunity: Rethinking contraindications in organ donation. A 5-Year UAE analysisREGINALDO BONI (AE)Multidrug-resistant donor-derived infections in solid organ transplantation: a systematic review and meta-analysis of transmission risk factorsCarolina Lopes (BR)Invasive fungal infections in heart transplants: A ten-year, single centre experience from subtropical AustraliaKanthi Vemuri (AU)10-year cohort of donor-derived disease in solid organ transplantation in Germany from 2016-2025Klaus Böhler (DE)Evaluation of empiric intraoperative antibiotic regimens for coverage of donor-derived infection in lung transplantation: A single-center retrospective studyzhenyu zhang (CN)Parasitic infection related organ failure and transplantation: A systematic review and individual patient data meta-analysisTuerhongjiang Tuxun (CN)Identification and validation of clinical phenotypes in liver transplant donors and recipients to predict early mortality and infectionsCecilia Bonazzetti (IT)Legionella pneumonia: Comparison between solid organ transplant and hematopoietic stem cell transplant recipientsHolenarasipur Vikram (US)High burden of tuberculosis and invasive fungal infections after heart transplantation in TB-endemic setting: a 20-year cohort from ThailandPakpoom Phoompoung (TH)Community-Acquired Respiratory Virus Burden in Heart Transplant Recipients: A Decade of Real-World Epidemiology and Vaccination Uptake, 2015–2024German Contreras (US) -
15:30–16:30
Clinical pharmacology
Chairs: Teun van Gelder (NL); Steven Ivulich (AU)
Kidney allograft donor ABCB1 pharmacogenotype predicts long term vascular fibrous thickening and tubular atrophy – pharmacogenomic analysis of a prospective Australian cohortJoshua Lawrence Lee (AU)Mechanism study of Tacrolimus inhibiting FXR mediated toxicity of renal tubular epithelial cellsZHAOFENG LIU (CN)BAP-Tac (BuccomucoAdhesive Patch-based Tacrolimus) Delivery System: The Next-Generation of Tacrolimus AdministrationSmita Pattanaik (IN)Hidden Interaction: Dulaglutide Significantly Alters Immunosuppressant Pharmacokinetics After Kidney TransplantationNuria Montero (ES) -
15:30–16:30
Education to outcomes: Enhancing organ donation through training, technology, and public insight
Chairs: Ala Ali (IQ); Susu Zughaier (QA)
The Mighty Method™: A Structured Pedagogical System for Scalable, Evidence-Informed Organ Donation Education in ChildrenRoydon Turner (GB)The Mighty Engine: A Traveling Museum Exhibit Advancing Early Health Literacy and Organ Donation Awareness Through Experiential LearningPeggy John (CA)Patient Satisfaction and Self-Rated Health After Kidney Transplantation in Vietnam: Are Subjective Outcomes Aligned with Clinical Status?Hien Nguyen (VN)Revolutionizing organ donor evaluation: A reproducible clinical framework for potential donor evaluation. UAE Results - 5 years experienceREGINALDO BONI (AE) -
15:30–16:30
Transplant outcomes and donor biology in the context of multiorgan and regenerative transplant innovation
Chair: Elias David-Neto (BR)
Donor outcomes in living donor liver transplantation for acute liver failure – a prospective cohort study from the International LDLT RegistryThe International Living Donor Liver Transplant Registry Collaborative (CH)Multimodal Baseline Renal Function Assessment Improves Prediction of One-Year eGFR After Living Kidney DonationRehan Ansari (US)First In human Successful CRISPR/Cas9 Gene Therapy (Exagamglogene Autotemcel) in a Heart Transplant Recipient with Beta-Thalassemia MajorRabi Hanna (US)Understanding the Relationship Between Pre-Implantation Kidney Allograft Biopsies and Early Transplant Outcomes: Insights from a Canadian Transplant CentreSang Joseph Kim (CA) -
16:45–18:00
Workshop Sessions / Industry Symposium / Poster Sessions
-
16:45–18:00
Sex, cancer, and the graft: What women need most from transplant care
Chairs: Karen Keung (AU); Nazia Selzner (CA)
Do women do better or worse – What the data say across cancer and transplant?Brenda Maria Rosales (AU)Screening, hormones, and birth plans: a playbook for female recipientsSakhee Kotecha (AU)Post transplant care: Patient perspectivesNicole Jane Scholes-Robertson (AU) -
16:45–18:00
Transplant without borders: Collaborative solutions for global kidney care
Chairs: Germaine Wong (AU); Medhat Askar (QA)
The global interdependence of health and the burden of kidney disease as a pressing public health priorityBenita Padilla (PH)Transplant knowledge and skills transfer: the role of collaborative partnerships in reducing disparities in kidney disease-related morbidity and mortalityShyam Bihari Bansal (IN)Overcoming the challenges in achieving equity in global access to kidney transplantationBeatriz Domínguez-Gil (ES) -
16:45–18:00
Optimizing cardiometabolic health across the lifespan following transplantation
Moderator/PanelistKaren Dwyer (AU)Moderator/PanelistBrenda Maria Rosales (AU)Moderator/PanelistAmanda Sluiter (AU)PanelistNuria Montero (ES)PanelistEmma Tumilty (AU)PanelistZhejia Tian (DE)PanelistPatricia Scheetz (AU)PanelistJohn Lafferty (AU)
-
16:45–18:00
Poster Session 1
-
17:00–18:00
Industry Symposium
-
18:00–20:00
Networking Events
-
18:00–19:00
WIT Networking Event
-
19:00–21:00
Early Career Networking
Tuesday, September 22, 2026
-
07:00–08:00
Bridge2Life Corporate Breakfast Symposium on Scaling better outcomes: The role of HOPE in contemporary transplant programs
Organized by
-
08:00–09:00
Morning Abstract and Concurrent Sessions
-
08:00–09:00
Prediction of kidney transplant outcomes
Chairs: Tracey Ying (AU); Vikas Sridhar (CA)
A dynamic prediction model for transplant renal artery stenosis based on donor atherosclerotic lesions at the renal artery ostiumYiling Fang (CN)Impact of baseline isoagglutinin titer on outcomes in ABO-incompatible kidney transplantation: a French multicenter studyLionel Couzi (FR)Prognostic significance of early donor-derived cell-free DNA elevations after kidney transplantationDidier Mandelbrot (US)The impact of the type of post-transplant thrombotic microangiopathy on graft and patient outcomesEkaterina Ivanova (RU)Performance of Computable Phenotypes for Identification of Immunosuppression Related Complications in Kidney Transplant Recipients within the Patient-Centered Clinical Research NetworkVikas Dharnidharka (US)Molecular HLA matching as predictive factors for graft and patient outcomes in kidney transplantation: a systematic reviewKristy Nguyen (AU)The Canadian Highly Sensitized Patient (HSP) program: post–deceased donor kidney transplant survival comparable to national benchmarksKyle Maru (CA)Mediation analysis of delayed graft function and graft loss in kidney transplant recipientsDharshana Sabanayagam (AU) -
08:00–09:00
Omics in transplantation 2
Spatial single-cell mapping of liver allograft inflammation reveals distinct immune microenvironmentsTimucin Taner (US)Ccl5⁺ Macrophages Orchestrate Immunometabolic Interaction in Cardiac Allograft Rejection via Integrated Multi-OmicsQuan Zhuang (CN)Tissue-resident hematopoietic stem cells in the liver provide a functional basis for post-transplant microchimerismAllison Banuelos (US)Temporospatial profiling reveals three-way T cell chimerism and alloreactivity in a patient receiving a second intestinal transplantJianing Fu (US)
-
08:00–09:00
Mechanisms and management of AMR in kidney transplant recipients
Chairs: Wenshi Jiang (CN); Ruth Sapir-Pichhadze (CA)
Prolonged CD38 targeting with felzartamab achieves sustained suppression of antibody-mediated rejection in kidney transplant recipients: a biomarker-guided open-label phase 2 extensionKatharina Mayer (AT)Unbiased and Spatial Proteomics of Kidney Allograft Biopsies: Terminal Complement Proteins Dominate Chronic Active Antibody Mediated RejectionMaya Allen (CA)HLA Eplet-based risk stratification for DSA and ABMR after kidney transplantation with validation of immunogenicity and immunoreactivityZhou Guxiang (CN)Tissue effector signatures define distinct mechanistic phenotypes of microvascular inflammation and predict kidney allograft outcomes beyond DSA and C4dAlev Ok Atılgan (TR)Novel IgG-Degrading Enzyme Therapy for the Desensitization in Highly HLA-sensitized Kidney Transplant Recipients: A Phase 2 StudyYongbo Wang (CN) -
08:00–09:00
Immunoregulation: Tolerance versus rejection 1
Chair: Alexandra Sharland (AU)
Microplastic Exposure Accelerates Graft Loss in a Murine Chronic Cardiac Allograft Rejection ModelQuan Zhuang (CN)Single-cell multi-omics characterization of rejection in transplanted kidneys reveals key cell types and a regulator of chronic rejectionBingxuan Zheng (CN)Leucine attenuates allograft rejection by reversing memory-like NK cell responses via subset redistributionJifu Ge (CN) -
08:00–09:00
Emerging challenges in transplantation: Allocation, risk prediction, and long-term outcomes
Chairs: Lachlan McMichael (AU); Ross Francis (AU)
The rate of glomerulosclerosis as an appropriate criterion for allocation of marginal kidneys into single or dual kidney transplantationJiaSheng Xie (CN)Body-composition abnormalities and post-transplant prognosis in hepatocellular carcinoma liver transplantation: a multi-task clinical surrogate modelJinyan Chen (CN)Impact of prior kasai portoenterostomy on liver transplantation outcomes in children with biliary atresia: a single-center retrospective cohort studyWanglong Xiao (CN)Initial kidney graft function and its association with short- and long-term graft outcomes: a paired kidney analysisWai Lim (AU)Development of a Machine Learning Model to Predict 90-Day Mortality Risk After Deceased-Donor Kidney TransplantationSergio Salcedo Herrera (CO)Liver transplantation disparties by ABO blood type in the machine perfusion eraElizabeth Swanson (US) -
08:00–09:00
Delivering value in liver transplantation: Innovation, resources, and the future of care
Chair: Gabriel E. Gondolesi (US)
Implementing change and managing resources: Can we do both?Alfred Kow (SG)Defining value in liver transplantation: Focusing on what mattersJulie Heimbach (US) -
08:00–09:00
Long-term outcomes and risk stratification after liver transplantation
Chairs: Simone I. Strasser (AU); Oscar Cesar Imventarza (AR)
Saroglitazar improves post-liver transplant metabolic associated steatotic liver disease- A randomized controlled trial- interim analysisDinesh Jothimani (IN)Harnessing the estrogen-PARP axis: A key to enhancing liver graft survival and combating fibrosisBinnaz Handan Ozdemir (TR)Early Post-Transplant Recipient-Derived Cell-Free DNA Predicts One-Year Graft Survival in Liver Transplant RecipientsEun-Ki Min (KR)25 years of pregnancy outcomes after liver transplantationLisa A. Coscia (US)Temporal changes in graft failure over three decades of liver transplantation: Insights from ultra-long-term outcomes with well-maintained follow-up at a single centerMasaaki Hirata (JP)Post-transplant MASLD does not adversely affect long-term survival or cardiometabolic outcomes following liver transplantationKi Sang Jung (KR) -
08:00–09:00
Expanding transplant access: Innovations in training, simulation, and global collaboration
Chairs: Jen Li (AU); Marti Manyalich Vidal (ES)
World’s First Heart to Heart Exchange: Connecting Children in Canada and South Africa Through Organs, Habits and KindnessPeggy John (CA)World’s First Heart to Heart Exchange: Connecting Children in Canada and South Africa Through Organs, Habits and KindnessDavid Thomson (ZA)Barriers to Kidney Transplantation Among Dialysis Patients in a Low-Middle Income Country: A Large Patient-Reported SurveyRuchir Dave (IN)MNGIE: Largest single-center experience of a comprehensive multidisciplinary clinic and diverse therapeutic methodologiesEhab Abufarhaneh (CA)SimU-Skin: A 4D Tactile Simulation Platform to Improve Patient Recognition of Sentinel Skin Flap Changes Following Solid Organ TransplantationOmar Quidwai (IE)Global kidney transplant simulation (Global-KiTSi) model: Feasibility of a low cost LMIC scalable modular kidney transplant surgery simulation platform using three dimensional printed negative moulds and silicone casting.Bishow Bekhyat Karki (GB)Simulation based surgical skills training in liver transplantation: A scoping review of low-cost, high fidelity liver transplant simulation models in resource limited settings.Bishow Bekhyat Karki (GB) -
08:00–09:00
Optimizing pancreas and islet transplantation: From donor selection and graft preservation to functional outcomes
Chairs: John Kanellis (AU); Raja Kandaswamy (US)
Membrane-anchored ROS scavenger protects pancreatic islets from hypoxic injury by preserving surface thiol homeostasisJianmin Wu (CN)Post-Transplant Diabetes in SPKLucas Garcias (AR)Challenging the marginal label: Pediatric donors in simultaneous pancreas–kidney transplantationBelmin B J Winston Gysley (IN)Expanding Candidacy in SPK Transplantation: Impact of Age, BMI, C-Peptide, and Insulin Requirement on Recipient OutcomesElif Kortan (US)Biophysical profiling of human pancreatic organoids identifies mass mensity as a size-independent metric of maturation and functionGiuseppe Pettinato (US)Temporal trends in surgical morbidity and outcomes following Simultaneous Pancreas Kidney Transplantation: A 10 year single centre experienceSai Praneeth Reddy Perugu (IN) -
08:00–09:00
Viral infections in transplantation
Chairs: Monica Slavin (AU); Bradley Gardiner (AU)
Mapping the BK polyomavirus MHC class I immunopeptidome to advance antiviral immune target discovery in kidney transplantsTirath Dwivedi (AU)Unsupervised Machine Learning Reveals Early BKPyV DNAemia Trajectories That Improve the Prediction of Kidney Allograft OutcomesGang Huang (CN)Breakthrough CMV DNAemia in solid organ recipients on primary valganciclovir prophylaxisSara Belga (CA)When CMV donor/recipient risk is not one-size-fits-all: Demographic and socioeconomic modification of CMV-associated mortality after heart transplantationMaheen Abidi (US)Extended antiviral prophylaxis mitigates impact of cytomegalovirus infection in seronegative lung transplant recipientsManushika Watagodakumbura (AU)Early Initiation of Letermovir Prophylaxis Prevents Cytomegalovirus Infection After Liver Transplantation: A Prospective Single-Center StudyKatsunori Sakamoto (JP)CMV specific cell mediated immunity profile in Indian kidney transplant recipientsRamanand Sivaprasad (IN) -
08:00–09:00
Novel immunosuppression
Chairs: DongJin Joo (KR); Marcelo Cantarovich (CA)
Phase 2 BESTOW trial and the BESTOW EXTENSION: Evaluating the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejectionAndrew B. Adams (US)CCL22-engineered MSCs modulate immune crosstalk to shape an immunosuppressive microenvironment for graft protectionYanan Li (CN)Efficacy and safety of everolimus added to Tacrolimus/Mycophenolate/Prednisone in HLA-sensitized kidney transplant recipients: A randomized controled trial.Elias David-Neto (BR)Targeted Elimination of ABO-Specific B Cells via Bispecific T-Cell-Engaging Antibody Conjugates for ABO-Incompatible Kidney TransplantationJoon Young Jang (KR)CCR10 Defines a Potent Regulatory T Cell Subset Essential for Kidney Transplant Tolerance through Enhanced Foxp3 Lineage StabilitySiyue Chen (CN)Comparative effectiveness of thymoglobulin versus basiliximab for induction immunosuppression in older kidney transplant recipients: A target trial emulationKatharine Krupp (US)Bioequivalence of generic immunosuppressants in kidney transplantsAnders Asberg (NO) -
08:00–09:00
Pediatric treatments on the Horizon
Chairs: Katherine E. Twombley (US); Matthew Sypek (AU)
The micorbiome and transplantationMaria-Luisa Alegre (US)Regulatory cell therapy for solid organ transplantationFadi Issa (GB) -
08:00–09:00
Bridging gaps in transplantation: Equity, access, and unmet needs worldwide
Chairs: Riadh Fadhil (QA); Anantharaman Vathsala (SG)
Estimating the scale of unmet solid organ transplantation need in India: a demographic scenario analysis to 2040SAURABH PURI (IN)Financial sustainability of Transplant Programs in low middle-income countries. A snapshot of models providing “free of cost” transplant services.Mirza Zafar (PK)Qualitative methodologies exploring pregnancy care for First Nations women with kidney transplantation: An Aboriginal kidney care together improving outcomes now (AKction2) co-designed studyNishanta Tangirala (AU)“I won’t offer a kidney that I don’t think they should accept”: Nephrologists’ perspectives on patient involvement in declined deceased donor kidney transplant offersAlison Weightman (AU)The economics of kidney replacement therapy in Tanzania: a generalizable, state-transition model for policy-driven cost-effectiveness analysesAlan Zambeli-Ljepović (US)A Time-to-Equivalent Risk (TiTER) for decision-making in deceased donor kidney transplant candidatesJin Hyeog Lee (KR)Multidimensional Analysis of Barriers to Organ Donation and Transplantation Development in Asia: A Mixed-Methods Study Based on Questionnaire Surveys and Expert ConsensusXiangxiang He (CN)Sex Disparities in Transplant Waitlisting- Differences by Race, Ethnicity, and AgeMara McAdams DeMarco (US) -
09:15–10:30
TTS Plenary's Plenary
- 09:15–10:30 TTS President's Plenary
-
10:30–11:00
Coffee Break / Exhibits and Poster Viewing
-
10:30–11:00
Coffee Break
-
11:00–12:00
Abstract and Concurrent Sessions
-
11:00–12:00
Donor risk and recipient outcomes in kidney transplantation
Chairs: Angela Webster (AU); John S. Gill (CA)
The Impact of The Modified Kidney Donor Profile Index on The Non-use of Kidneys from Donors with Hepatitis CTarek Alhamad (US)Does pre-donation cardiac arrest affect post-transplant outcomes in kidney transplantation: a UK NHSBT Registry Data AnalysisZaid Al-Amiedy (GB)1-year outcomes of kidney transplantation from donation after circulatory death using normothermic regional perfusion (NRP) – a single-center experienceAlex Zendel (US)Long-term outcomes of kidneys from donors following medical assistance in dyingFrançois Méthot (CA)Donor factors associated with poor early graft outcomes – a retrospective observational study over two decades from the ANZDATA registryGina Davis (AU)Imaging-based nephron mass estimation using BSA-normalized CT renal volume predicts early remnant kidney dysfunction in living kidney donorsManish Malik (IN)Eplet mismatch does not predict outcomes in living related kidney transplantation as induction therapy overrides molecular riskKAPIL VIJAYKUMAR GOTHWAL (IN) -
11:00–12:00
Immunosuppression: Experimental and clinical
A Novel Biomarker for Immunosuppression MinimizationMarilia Cascalho (US)Beyond tacrolimus levels: NFAT-Residual Gene Expression as a Renal Transplant Rejection and Infection PredictorRitika . (IN)Engineering tacrolimus-resistant A2-CAR Tregs for use in solid organ transplantationRobert Wright (CA)
-
11:00–12:00
Immunologic risk, donor factors and predictive modelling of kidney transplant outcomes
Chairs: Alessandra Orsillo (AU); Kate Wyburn (AU)
Homozygosity at HLA-A, especially the A24 antigen, is an independent risk factor for higher PRA post-transplant and reduced opportunities of subsequent transplantAnne Taverniti (AU)Impact of donor hypertension on kidney transplant outcomes - An analysis of the Collaborative Transplant Study (CTS)Christian Unterrainer (DE)Temporal decay in the performance of Cox proportional hazards models for deceased-donor kidney graft survivalAniket Sinha (AU)Serum induced trained immunity responses are associated with clinical outcomes after pediatric kidney transplantationLongshan Liu (CN)Gene Spark: Genetic Survey of Paediatric Kidney Transplant PatientsAnanya Deshpande (AU)Longitudinal Graft Function Trajectories in Crossmatch-Positive Living Kidney TransplantationToshihito Hirai (JP) -
11:00–12:00
Immunoregulation: Cell signalling 1
Targeting VDR-sirt5-PHB2-mediated mitophagy to reverse vascular endMT and prevent chronic renal allograft dysfunctionQinghuan Shen (CN)Phosphodiesterase-5/5-HT2B antagonism regulates fibrotic potential of renal allograft fibroblasts isolated from renal allograft rejection patients by targeting TGF-βeta1-Src-ERK1/2-STAT3 PathwaySaurabh Chaturvedi (IN)G-MDSC derived LETS1 promotes mesenchymal stem cell differentiation into myofibroblasts via targeting TGF Beta Receptor I in renal fibrosisXinhao Niu (CN)A mechanistic model to investigate Non-HLA Mismatches in LIMS1-GCC2.Madhav Menon (US)Targeting Innate Allorecognition Via CD47-Sirpa Prolongs Cardiac Allograft Survival In Presensitized RecipientsMartin Oberbarnscheidt (US)
-
11:00–12:00
Multi-omics and immune profiling in transplantation: Kidney-focused advances with cross-organ insights
Deep Characterization of the Kidney Transplant Immune Microenvironment via Multimodal Deep Learning and Single-Cell Spatial TranscriptomicsJiaheng Wu (CN)Distinguishing Pathogenic Alloimmunity from Immunological Noise in DSA-Negative Kidney Rejection: A Multimodal Framework Validated in GSTT1-Null RecipientsXiantian Pan (CN)Integration of a pre-transplant 15-protein serum proteomic signature predicts recurrence after liver transplantation for HCC: A multicenter KOTRY registry studySuk Kyun Hong (KR)Potential Value of Targeting the TIM-4/PS Signaling Pathway in Promoting Immune Tolerance in Kidney TransplantationQiang Fu (CN)Genome-wide investigation of variants associated with kidney allograft survivalAngelita Liang (AU)
-
11:00–12:00
Transplant outcomes, bridging strategies, and global advances in liver transplantation
Chairs: Avik Majumdar (AU); Pranjal Modi (IN)
HLA-DQ molecular mismatch-derived risk score predicts acute rejection and development of de novo donor-specific antibodies in pediatric liver transplantationAgostina Arrigone (AR)Liver transplantation after neoadjuvant TACE in HCC: impact of cone-beam CT on bridging and downstaging strategies assessed by the Metroticket 2.0 modelSergey Astapovich (RU)Post-Transplant Lymphoproliferative Disorder in Paediatric Liver Transplantation: A National Centre Experience from New ZealandYae Jhee Lee (NZ)Outcomes of liver transplantation for metabolic dysfunction–associated steatotic liver disease in the United StatesREZA SAIDI (US)Perioperative glucose alterations and liver transplantation outcomes: A Mongolian cohort studySarnai Erdene (MN)The role of international collaboration in developing transplant programs: A success story from TTS-ILTS paired transplant centers program from the Paired ProgramSergelen Orgoi (MN)Establishing a protocol for liver transplantation in unresectable colorectal liver metastases: Preliminary results of an Australian clinical trialArsalan Bakhtiar (AU) -
11:00–12:00
Vascularized composite allotransplantation: Expanding frontiers in function, immunity, and clinical translation
Defining long-term functional recovery in face transplantationBruce Gelb (US)Human limb preservation using oxygenated machine perfusion with hemoglobin-based oxygen carriers modulates hypoxia and immune injury pathwaysVarun Kopparthy (US)Vascular Composite Allograft Transplantation – A Single Center Experience From IndiaShruti Tapiawala (IN)Emerging divides in attitudes towards uterus transplantation among health professionals in Australia and New ZealandHayley Mallinder (AU)Psychological and emotional profiles of Australian uterine transplant potential recipients: a comparison with international trialsTamika Baker (AU)
-
11:00–12:00
The journey to clinical xenotransplantation
Chair: Evelyn Salvaris (AU)
Development of the gene edited pigs to get us to the clinicPeter Cowan (AU)The road to regulatory approval for clinical transplantationMuhammad Mohiuddin (US) -
11:00–12:00
Expanding living donor liver transplantation: Emerging evidence and clinical advances
Chair: Kwang Woong Lee (KR)
Liver transplantation from donation after circulatory death in the United States: Elderly donors emerge as a critical resourceAllan Massie (US)Quality of Life After Robotic Living Donor Hepatectomy: A One-Year Prospective Analysis of Donor and Recipient DeterminantsDieter Broering (SA)A comparison of total intravenous and volatile anesthesia in living donor hepatectomy: a global prospective cohort study from the International Living Donor Liver Transplant Registry (LDLTregistry.org)The International Living Donor Liver Transplant Registry Collaborative (CH)Laparoscopic Donor Left vs. Right Hepatectomy: A Propensity Score-Matched Analysis of Donor Safety and OutcomesEunjin Lee (KR) -
11:00–12:00
Lung transplantation outcomes and allograft dysfunction: From mechanisms to clinical prevention strategies
Chairs: Gregory I. Snell (AU); Jyotika Prasad (AU)
Clinical, histological and tissue proteomic features of decline after idiopathic acute lung allograft dysfunctionPamela Karas (AU)Predicting acute kidney injury following lung transplantation: development and internal validation of perioperative prediction modelsShogo Trevena (AU)Family Experiences and Ethical Acceptability of Lung uDCD Authorization in an Opt-In SystemJingzhi Xu (US)Donor Lung Microbiome and Metabolic Signatures Predict Primary Graft Dysfunction After Lung TransplantationGuodong Wu (CN)Randomized controlled trial comparing immediate versus extended-release tacrolimus in lung transplant recipients: the REVOLUTION trialJuul Daamen (NL)Excellent Long-Term Outcomes in Paediatric Lung Transplantation Within a Centralised, Co-located Adult ProgramMiranda Paraskeva (AU) -
11:00–12:00
Psychosocial, communication and educational aspects of donation and transplantation
Chairs: Estephan Arredondo (ES); Bronwyn Levvey (AU)
You don’t know what you don’t know: Developing video-based educational resources for prospective kidney transplant recipientsDarren Manden (NZ)Exploring lived experiences of kidney graft loss through narrative podcastingAnita Slominska (CA)Barriers to effective communication about kidney graft failure: findings to guide intervention developmentAnita Slominska (CA)“I’ve got no organs that are usable”: Indigenous perspectives on gifting organs following assisted death, New ZealandTess Moeke-Maxwell (NZ)'Recognizing how much the kidney transplant would hold me back': A qualitative explorative study and a digital storytelling project with young adult kidney transplant recipientsChloe Wong-Mersereau (CA)Posttraumatic Distress Symptoms in Patients on Mechanical Circulatory SupportChristiane Kugler (DE)Psychological resilience and post-kidney transplant psychosocial outcomesKathleen Gaudio (CA)The role of community in the well-being of living kidney donorsKathleen Gaudio (CA) -
11:00–12:00
Global Transplantation: The GODT Report Analyzes Activities Around the World
Chairs: John J. Fung (US); Nadey Hakim (GB)
Global observatory on donation and transplantation (GODT)Beatriz Domínguez-Gil (ES)Global donation and transplantation activities. An assessment of 2024 GODT dataFriederike Martin (DE)PanelistsStefan Tullius (US)PanelistDimitri A. Raptis (SA)PanelistDavid Thomson (ZA) -
11:00–12:00
Optimizing and utilizing old organ donors
Chair: Helen Opdam (AU)
Setting the stage: Older organs - clinical need, ethical and economic considerationsKrista Lentine (US)Objective quality criteria of old organsVarvara Kirchner (US)Old organs and ex vivo treatmentJasper Iske (DE) -
11:00–12:00
Pediatric liver
Chairs: Helen Evans (NZ); Michael Stormon (AU)
HOPE improves outcomes of ex situ split liver grafts in pediatric liver transplantationJavier Serradilla (ES)Incidence of cognitive dysfunction in children after liver transplantation: a systematic review and meta-analysisQingqing Zhou (CN)Liver transplantation for gestational alloimmune liver disease outcomes analysis from retrospective cohort and national case seriesShreya Tamma (US)Infant versus paediatric liver transplantation: technical and survival outcomes in a single-centre cohort studyYang Yang Lee (SG)The Survival Benefit of Pediatric Liver TransplantationAli Abbasi (US) -
11:00–12:00
Therapeutic organ perfusion: From organ rescue to advanced clinical applications
Chairs: Dale Gardiner (GB); Sarah Scheuer (AU)
First-in-Human Application of Extracorporeal Diseased Liver Perfusion Support (EDLPS) for Liver FailureXiaoshun He (CN)Development of the first pediatric DCD normothermic machine perfusion program: meeting the unmet need in pediatric liver transplantationChun-Sing (Kevin) Huang (US)The First 500 Kidneys Rescued Using Subnormothermic Acellular Perfusion (SNAP) at a Centralized FacilityGiselle Guerra (US)Subnormothermic machine perfusion for small intestinal ischemia reperfusion injury suppression and functional maintenanceSatoshi Muto (JP)Impact of Normothermic Perfusion Strategies on Early Liver Transplant Outcomes: A Comparison of On-Site versus Back-to-Base StrategiesSantosh Nagaraju (US) -
12:00–13:30
Lunch Break / Industry Symposia / Lunch with Experts & Mentors
-
12:15–13:15
Astellas Corporate Lunch Symposium on Strengthening the foundation: From tacrolimus consistency to durable graft outcomes
Organized by
-
12:30–13:15
Lunch and Learn Roundtable
Organ preservation, rejuvenation, and perfusion techniquesStefan Tullius (US)Living donor kidney transplantation & paired exchangeVivek Kute (IN)BK GuidelinesCamille N. Kotton (US)"Organ Donation: From Death to Life". How to improve education about organ donationDavid Thomson (ZA)Grant ManagementShaifali Sandal (CA)Transplant immunology & kidney injuryNatasha Rogers (AU)Nursing Leadership in Transplant and Donation SystemsAnne Floden (SE)Roundtable MentorNicole Isbel (AU)Roundtable MentorPeter G. Stock (US)Roundtable MentorWenshi Jiang (CN)Roundtable MentorMarcelo Cantarovich (CA)AMR in kidney transplant recipientsWilliam Mulley (AU)What strategies can effectively prevent unethical practices in donation and transplantation?Maria Amalia Matamoros (CR)DCD thoracic transplantGregory I. Snell (AU)
-
13:30–15:00
SOTA, Thematic and Concurrent Sessions
-
13:30–15:00
Targeting immune cell metabolism to control alloimmunity
Chairs: Alexandra Sharland (AU); Mariam Alexander (US)
How T cell metabolism regulates function and survivalCarl Atkinson (US)Treg metabolism and the impact of metabolites on their function and disease progressionLing Lu (CN)T cell landscapes following hematopoietic stem cell transplantationAntiopi Varelias (AU) -
13:30–15:00
Redefining Surgical Excellence: Metrics, Equity, and Global Perspectives
Chairs: Animesh Singla (AU); Peter G. Stock (US)
Novel outcome metrics in surgeryPierre-Alain Clavien (CH)Driving quality improvement through global surgical registriesDimitri A. Raptis (SA)Ensuring diversity in the transplant surgery workforceKendra Conzen (US) -
13:30–15:00
Deceased Donation Research: Findings and Future Directions
Chair: Dominique Martin (AU)
Donor intervention studies – ethical and practical challengesDale Gardiner (GB)Deceased donor physiological management researchGary F. Marklin (US)Thoracic ex-situ machine perfusion researchSarah Scheuer (AU)Biobanks for researchClaire Gordon (AU)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Pluripotent stem cells and regenerative medicine: the future of transplantation?
Pluripotent stem cells: Where are we in building new lungs?Rhiannon Werder (AU)
-
13:30–15:00
Biology and beyond: Multiple dimensions of transplantation
Chairs: Yolanda Becker (US); Philip O'Connell (AU)
Addressing gender disparity in access to pediatric kidney transplantation in IndiaKinnari Vala (IN)Social and cultural conflicts in uterine transplantationLimor Meoded Danon (IL)Impact of sex on cardiovascular outcomes after pediatric kidney transplantationRizky Indrameikha Sugianto (DE)Intersection of sex/gender, and cancer after transplantationBrenda Maria Rosales (AU) -
13:30–15:00
Life after transplant: Supporting movement, confidence, and long-term recovery across all levels of ability (WTGF)
Clinical perspective: Encouraging safe physical activity after transplantGeoffrey McCaughan (AU)Panel discussion: Supporting all patients to moveDiscussion Period (AU)
-
13:30–15:00
Transplanting Against the Antibody Odds
Chairs: Ankit Sharma (AU); Anne Halpin (CA)
Overview of new HLA tools for measuring antibodies and rapid high resolution sequencingSandra Tafulo (PT)Crossing DSA in lung transplant: Is necessity the mother of invention?Kieran Halloran (CA)Immune memory responses: Unmasking the hidden antibody potentialGonca E. Karahan (NL)Organ allocation strategies for HLA compatibilityPhilip Andrew Clayton (AU) -
13:30–15:00
Emerging infectious diseases in transplant ID
Chair: Olivia Smibert (AU)
Climate change and the changing epidemiology of transplant infectionsWanessa T. Clemente (BR)On the move: Migration and the globalization of emerging pathogensMonica Slavin (AU)New outbreaks of old diseases: Measles and other re-emerging threats in transplantationCameron Wolfe (US)Disease X and vaccineDeepali Kumar (CA) -
13:30–15:00
Honouring voices, changing systems: Indigenous leadership in transplant equity
Chairs: Jaquelyne Hughes (AU); Stephen McDonald (AU)
Building an indigenous lived experience database in organ donation and transplantationCaroline Tait (CA)Ka whawhai tonu, ka haere ake: Fighting to advance transplant equity in Aotearoa New ZealandCurtis Walker (NZ)Wangkanthi Purdita Purruna Naalitya - Talking Kidney Health for you MobStephen McDonald (AU)Panel Discussion and Q&ADiscussion Period (AU) -
13:30–15:00
Artificial intelligence (AI) in Transplant Education
Chair: Harry Robertson (AU)
From concept to classroom: How to start using AI in transplant education?Susu Zughaier (QA)Mixed reality technology in organ transplantationAlfred Kow (SG)AI in Transplantation: AI capabilities, applications and responsible useBill Simpson-Young (AU)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Global collaboration in organ transplantation: Advancing ethical access, innovation, and sustainability
Chairs: Rajdeep Das (US); Marcelo Cantarovich (CA)
Global organ sharing & research collaborationsAxel Rahmel (DE)Economics of transplantationVasanthi Ramesh (IN)Capacity building in low-resource settingsMedhat Askar (QA)Ethical, cultural & patient-centered considerationsJeremy Chapman (AU) -
13:30–15:00
Transplant Oncology: Peering Over the Horizon
Chairs: Kwang Woong Lee (KR); Mohamed Rela (IN)
Liver transplantation for unresectable hilar cholangiocarcinoma: Who truly benefits?Julie Heimbach (US)Neuroendocrine tumours and liver transplantation: Time to move beyond traditional boundaries?Takashi Ito (JP)Intrahepatic cholangiocarcinoma and liver transplantation: Pushing the limits of what’s surgically and biologically possibleSudha Kodali (US)Liver transplantation for hepatoblastoma: Does biology drive the decision to transplant?Mohamed Rela (IN)Liver transplantation for non-hepatoblastoma paediatric tumours: LT as a curative tool?Seisuke Sakamoto (JP) -
13:30–15:05
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 1
Chairs: Ravi Mohanka (IN); Swarnalatha Guditi (IN); Divyesh Engineer (IN); Amit Pasari (IN); Abi Abraham Mookanottle (IN); Amol Bhawane (IN); Sreebhushan Raju (IN); Manish Balwani (IN); Feroz Aziz (IN)
Government reforms to increase access to organ transplantation: Policy innovations and outcomesAnil Kumar (IN)Optimizing transplant outcomes through cost-effective immunological evaluation in LMICsManoj Gumber (IN) -
13:30–15:00
Obesity Management in Transplantation: Current Evidence and Practical Approaches
Chairs: Dorry Segev (US); Marina Berenguer (ES)
Latest evidence on GLP-1s in transplantationBabak Orandi (US)Managing obesity without GLP-1s: Alternative strategiesAmanda Velazquez (US)Bariatric surgery in transplantation: Opportunities and challengesShashank R. Joshi (IN)Facilitating weight loss in individuals with frailty and sarcopeniaAstrid Ruiz-Margáin (MX) -
15:00–15:30
Coffee Break / Exhibits and Poster Viewing
-
15:00–15:30
Coffee Break
-
15:30–16:30
TSANZ President Session / Afternoon Abstract and Concurrent Sessions
-
15:30–18:00
TSANZ President's Prize Awards
Immune invisible kidney allografts: eliminating MHC II expression with cytosine base editing to prevent antibody-mediated kidney transplant rejectionAilish Barry (AU)Impact of Repeat HLA Mismatches on Graft Outcomes in Kidney Transplantation in AustraliaHenry Guo (AU)A single-cell imaging atlas of the peripheral immune system in kidney transplant recipientsGriffith Perkins (AU)Fatherhood and Kidney Replacement Therapy: Analysis of linked ANZDATA Registry and perinatal dataSu Jen Chua (AU)
-
15:30–16:30
Organ preservation 2
Chair: Henry Pleass (AU)
Metabolic reprogramming by modulation of histone lactylation improves liver graft preservation and functionXiao Tang (CN)Xenon-enhanced gaseous perfusion under high pressure: a scalable strategy for heart preservationAlexander Ponomarev (US)Histone acetylation improves liver graft function via ADCY3-cAMP-mediated metabolic reprogrammingZhoucheng Wang (CN)The First Demonstration of Kidney Allo- and Autotransplantation After 72 Hours of Simple, Cryoprotectant-Free Subzero Preservation, with Pilot Extension to 96–120 HoursAnthony Consiglio (US)Hypothermic Oxygenated or Normothermic Kidney Perfusion – Which Perfusion Technique Protects Mitochondria Best?Keyue Sun (US)Inhibiting ferroptosis alleviates cold-induced injury in porcine lung tissue slicesFernanda Yamamoto Ricardo da Silva (CA) -
15:30–16:30
Biomarkers, pharmacokinetics and kidney allograft outcomes
Chair: Toby Coates (AU)
Autonomous AI pathology and spatial transcriptomics reveal inflammatory niches driving i-IFTA in kidney allograftsHarry Robertson (AU)Combined genomic transplant and pharmacogenomic risk assessment for pediatric renal patients using Oxford Nanopore Adaptive SamplingKaren Sherwood (CA)A Multicenter Randomized Controlled Trial Of Urine CXCL10 Monitoring Post-Kidney TransplantJulie Ho (CA)Consistently Low Donor-derived Cell-Free DNA Identifies Allograft Stability In Kidney Transplant RecipientsHossein (Hoss) Tabriziani (US) -
15:30–16:30
Immunoregulation: Cell signalling 2
Spatial Transcriptome Analysis Identifies Endothelial HLA-F as a Prognostic Marker in Kidney Antibody-Mediated RejectionToshihito Hirai (JP)Reversing TCMR through inhibition of innate immune allorecognitionGeoffrey Camirand (US)The “inflamed self” – perturbations of the murine immunopeptidome during ischaemia-reperfusion injury and transplantationAlexandra Hill (AU)
-
15:30–16:30
Precision immunosuppression and therapeutic optimization in transplantation: Kidney-centered advances across solid organ care
Chairs: Shyam Bihari Bansal (IN); Yolanda Becker (US)
Edge-AI-enabled Aptamer Impedance Biosensor for Real-time Point-of-care Tacrolimus Therapeutic Drug MonitoringJuhan Lee (KR)10-year analysis of low-Tacrolimus/Everolimus versus regular triple therapy for elderly recipients. The nEVERold trialElias David-Neto (BR)Proton-pump inhibitors: an opportunity for deprescribing in the solid organ transplant populationAnna Posthumus (NL)Building model-informed precision dosing platforms for tacrolimus in lung, heart and bone marrow transplantationDirk Kuypers (BE)An algorithm-driven predictive strategy for personalized tacrolimus dosing in kidney transplant recipientsGuodong Chen (CN) -
15:30–17:00
Overcoming immune barriers in xenotransplantation: From innate recognition to gene-edited graft compatibility
Chairs: Alexandra Sharland (AU); Peter Cowan (AU)
Normothermic Machine Perfusion of Human Kidneys Using Triple-Knockout Pig Red Blood CellsYizhong Tu (CN)Human Thrombomodulin Improves Early Coagulopathy, but Innate Immune–Driven Injury Limits Survival in Pig-to-NHP Liver XenotransplantationZhongqiang Zhang (CN)Preformed and De Novo Xenoreactive IgM Antibodies Contribute to Early Xenograft Loss in Pig-to-Monkey Kidney XenotransplantationMan Zhang (CN)Sequential Allotransplantation After Failure of Pig-to-Rhesus monkey Kidney Xenotransplantation: A Case ReportMan Zhang (CN)Flow cytometry immune profiling provides early detection of rejection of islet xenotransplantsThanh Le (AU) -
15:30–16:30
Imaging and biomarkers to assess kidney allograft dysfunction
Chairs: Samuel Neeling (AU); Terence Kee (SG)
Integrated immune profiling distinguishes polyomavirus nephropathy from rejection phenotypes in kidney allograftsBinnaz Handan Ozdemir (TR)Donor-derived Cell-free DNA As A Prognostic Biomarker In Biopsy-negative Kidney-transplant RecipientsHossein (Hoss) Tabriziani (US)Ultrasound assessment of the effect of patient position and body shape on peri-operative renal transplant cortical resistive indices and perfusionCharles FISHER (AU)The influence of ultrasound guidance quality on kidney transplant biopsy outcomes: A systematic review and meta-analysisDavid Su (AU)Genetic association in patients with chronic kidney disease of undetermined etiology: An observational studytarun kumar (IN) -
15:30–16:30
Optimization strategies in living donor liver transplantation
Chair: Dimitri A. Raptis (SA)
The 2023-2025 Global Report Of The International Living Donor Liver Transplant Registry (LDLTgroup.orgEnrico Prosperi (IT)Risk-Benefit Benchmarking in Liver Transplantation for Hepatocellular Carcinoma: a cohort study based on the CLTR and UNOS databaseFengqiang Gao (CN)Impact of Preoperative Weight Reduction on Donor and Recipient Outcomes in Living Liver TransplantationJaehyun Kwon (KR)THE OUTCOMES OF RE-LIVER TRANSPLANTATION: A SINGLE-CENTER EXPERIENCEKyung Chul YOON (KR)Outcomes of highly urgent ABO-incompatible living donor liver transplantation in national databasesJAE-WON JOH (KR) -
15:30–16:30
Engineering immune compatibility in transplantation: Gene editing, cell therapy, and regenerative strategies
Construction and properties characterization of a novel ceramic membrane-based artificial kidney hemofilterLuoyi Chen (CN)Immortalized Hypoimmune Human Mesenchymal Stem Cells for Immunomodulation and Wound HealingKatrin Hacke (US)Periportal arginine deficiency drives macrophage senescence to blunt aged liver regenerationHaoran Hu (CN)CRISPRa-Mediated CTRP9 Gene Overexpression Prevents Graft Loss After Islet TransplantationXingshi Gu (CN)
-
15:30–16:30
Solving immune problems for the life of the allograft
Chairs: Xunrong Luo (US); Kieran Halloran (CA)
Single cell transcriptomic profiling focusing on donor reactive T cells of operational tolerance recipient after liver transplantationNAOKI TANIMINE (JP)10-year outcomes for autologous polyclonal ex-vivo-expanded Treg cellular therapy in renal transplantation (ONE study UK Treg Trial)Charlotte Yates (GB)Single cell spatial technologies in kidney allograft pathology- inflammation, fibrosis and beyondMariam Alexander (US)Direct and indirect allorecognition – more alike than we thought?Gavin Pettigrew (GB) -
15:30–16:45
Precision virology in transplantation: Immunity, diagnostics, and targeted therapies
Chairs: Matthew Roberts (AU); Tina Marinelli (AU)
The post-transplant lymphoproliferative disorders metagenomic shotgun microbial sequencing (PTLD-MSMS) study: clinical insights from the full cohortVikas Dharnidharka (US)Phase I Clinical Evaluation of Allogeneic Virus-Specific T Cell Therapy in Solid Organ Transplant Recipients with Refractory Viral InfectionsRajiv Khanna (AU)Measles immunity before and after solid organ transplantation: evidence for preserved protective neutralizing antibodyCamille N. Kotton (US)Proximal Tubule-Derived SPP1 Activates Proteotoxic Stress Response and CD8⁺ T Cell Exhaustion in BK Polyomavirus NephropathyYingzhen He (CN)Virologic clearance with maribavir by baseline cytomegalovirus DNAemia in solid organ transplant recipients: A post hoc analysis of phase 2 and 3 trialsDeepali Kumar (CA)Comparing the post-omicron transplant impact of SARS-COV2 and other respiratory viral infectionsBeatrice Sim (AU) -
15:30–16:30
TTS-ISN: Pregnancy in renal transplant recipients - Outcomes, barriers, and clinical management
in collaboration with:
Chair: Curie Ahn (KR)
The pregnancy after renal transplantation OUTcomes registry (PARTOUT) in the Netherlands with granular dataMargriet de Jong (NL)Assessing risk and overcoming barriers in pregnancy after kidney transplantationShilpanjali Jesudason (AU) -
15:30–16:30
Integrated machine perfusion strategies for DCD organ optimization and transplant outcomes
Chairs: John Whitlam (AU); Irene bello (ES)
Sequential NRP and hypothermic versus normothermic ex-situ perfusion in extended criteria DCD liver transplantationDaniele Pezzati (IT)A pragmatic alternative to commercial perfusion devices: routine liver machine perfusion using a heart–lung machineMikhail Boldyrev (RU)Early outcomes after sequential hypothermic, controlled oxygenated rewarming and normothermic machine perfusion combined with TPA thrombolysis for DCD liver graft optimisationAdam Philipoff (AU)Automated and continuous hypothermic to normothermic machine perfusion minimises injury in porcine livers and restores function in high-risk human liversHatem Sadik (GB)Routine use of the modified HTK-based perfusate for hypothermic oxygenated perfusion enables safe transplantation of suboptimal liver allografts: a single center experienceStepan Zubenko (RU)Impact of Hypothermic Oxygenated Machine Perfusion on Early Outcomes in Kidney Transplantation from Uncontrolled DonorsElmira Tenchurina (RU)Factors Associated with Prolonged Case Time in Deceased Organ DonationCarolyn Sidoti (US) -
15:35–18:10
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 2
Chairs: Shruti Tapiawala (IN); Gireesh MS (IN); Mohan Patel (IN); Raj Kanwar Yadav (IN); Dhananjai Agarwal (IN); Dhananjaya KL (IN); Pranjal Kashiv (IN); Ashish Sharma (IN); Narayan Prasad (IN); Arpita Ray Chaudhury (IN); Vikas Jain (IN); Sourabh Sharma (IN); Pankaj Shah (IN)
Making ABO-incompatible transplantation affordable for low- and middle-income countries: Scalable cost-reduction strategiesDeepak S. Ray (IN)HLA desensitization in transplantation in LMIC: Balancing access, cost, and clinical outcomesUmapati Hegde (IN)Integrating cell-free DNA surveillance into cost-effective organ transplantation pathways in LMIC settingsPratik Das (IN)Gender disparity in organ transplantation: Insights and lessons from LMICKhushboo Saxena (IN)Pioneering surgical techniques in transplantation: The global south contribution to global practicePranjal Modi (IN)ISOT position statements for increasing access to transplantationJigar Shrimali (IN) -
16:45–18:00
Basic and Translational Science - Part 2
Complement binding alone is insufficient to drive phagocytosis through liver macrophage enriched CRIg receptorBlayne Amir Sayed (CA)Spermine promotes thymic regeneration in aged mice to increase naive T cell reconstitution and restore antibody-induced transplant toleranceGaoping Zhao (CN)IVIG induces paradoxical activation of monocyte-derived antigen-presenting cells in immunologically stable conditionsMasato Shizuku (JP)Different Induction Strategies in Kidney Transplantation: A Comparative Analysis of Alemtuzumab, Alemtuzumab plus Eculizumab, and BasiliximabStanislav Shchekaturov (RU)Study on the mechanism of targeted complement inhibitor in regulation of mouse hind limb transplantationBiao Lei (CN)Influence of CYP genetic polymorphism on tacrolimus pharmacokinetics in renal recipients: Evidence in kazakh populationIslam Madadov (KZ)From fixed dosing to AUC-guided monitoring: Optimizing mycophenolate mofetil therapy in kidney transplant recipientsNuria Lloberas (ES)Attempt to minimize maintenance immunosuppressive therapy based on T and B cell epitope mismatch: Difference between PIRCHE-II and PIRCHE-T2Takaaki Kobayashi (JP)Corticosteroids attenuate Tacrolimus-induced chronic nephrotoxicity via suppression of tubular NF-κB/STAT3 signaling: A mouse-to-human translational studyTatsuya Hoshi (JP)Chimeric liver and immunosuppression withdrawal in long-term liver transplant recipientsWei-Chen Lee (TW)Detection and management of Latent TB in kidney transplant candidates. A retrospective study.Armelle Villalobos (CA)Safety and Outcomes of Kidney Transplantation Using Exceptional Distribution Increased-Risk Donors.Armelle Villalobos (CA)Donor-derived HHV-8 causing multicentric Castleman disease with Kaposi sarcoma after kidney transplantationCamille N. Kotton (US)PCR viral load thresholds corresponding to CMV antigenemia cutoffs in kidney transplant recipientsKENTA FUTAMURA (JP)Early detection of CMV dnaemia identifies recipients at risk for poor early outcomes after liver transplantationKyeong Sik Kim (KR)Prevalence of persistent infections in pre-kidney transplant patientsMónica Buonpensiere (DO)IgM-enriched intravenous immunoglobulin as adjunctive therapy in kidney transplant recipients with severe infections: A retrospective cohort studyNikolina Basic-Jukic (HR)Infections and surgical site complications following kidney transplantation: Risk factors and clinical implicationsValeria Ripa (US)SGLT2 inhibitors and the risk of urinary tract infections in kidney transplant recipients: A propensity score matched multicenter cohort studyYoonJU Kim (KR)Computational fluid dynamics modeling of donor liver cooling during hypothermic perfusion: Evidence for temperature gradient-driven heterogeneous ischemic injuryBakhtiyar Kazymov (RU)Therapeutic mild hypothermia in brain-dead donors: A systematic review and meta-analysisGrigorios Voulalas (GB)The efficacy of intraoperative dexmedetomidine on delayed graft function in patients receiving a kidney transplant: The KEYSTONE trial proposal.Jonathan Bannard-Smith (GB)DRSAb targeting ATP1A1 inhibits ferroptosis in renal ischemia reperfusion injury by reguating ACSL4Yixuan Li (CN)The usefulness of prebiotics-derived short-chain fatty acids in liver ischemia–reperfusion injury.Yoichiro Uchida (JP)IDHP protects against renal ischemia-reperfusion injury through HMOX1/ferroptosis pathwayChenguang Ding (CN)Lactylation-driven METTL3-mediated m6A modification of PCK1 aggravates tubular epithelial cell apoptosis in renal ischemia-reperfusion injuryChenguang Ding (CN)LEA29Y pigs facilitate a local break down of remodelling processes in post-ischemic myocardial scar formation under immunosuppressionHeinke Heymer (DE)Gut Metatranscriptome Pathways Associated with Mycophenolic Acid Pharmacokinetics in Kidney Transplant RecipientsAjay Israni (US)Gut microbiome stability across ABO compatibility in kidney transplantation: Longitudinal fecal microbiome and targeted metabolomics profilingJIN-MYUNG KIM (KR)Single cell analysis reveals an NK2 driven monocyte interaction axis in antibody mediated rejection after kidney transplantationJIN-MYUNG KIM (KR)APOE promotes fibrosis in DCD kidney transplantation by regulating macrophage lipid metabolism through the TREM2-PI3K/AKT pathwayQianchao Hu (CN)Region-Specific Mitochondrial Pathway Downregulation in BK Virus–Associated NephropathySoie Kwon (KR)Methionine deficient high fat diet induces stress responsive reprogramming in hepatic ILC1 and NK cells and promotes tumor growthYoshitaka SAEGUSA (JP)Cytokine and cardiovascular proteomics identify circulating biomarkers of allograft rejection in heart transplantationZeying Du (US)Integrated evaluation of thermal stability and operational outcomes in abdominal organ transport using LifeSafe organ transport containerArif Rahman (US)Cytokines profile in donation after cardiac death with sequential NRP and ex situ MPDaniele Pezzati (IT)First Experience with Normothermic Machine Perfusion in KazakhstanJamilya Saparbay (KZ)Surgeon perspectives and practice patterns of machine perfusion in liver transplantation in the United StatesJustin Steggerda (US)
-
16:45–18:00
Workshop Sessions / Industry Symposium / Poster Sessions
-
16:45–18:00
Multidisciplinary: Leveraging shared infrastructure for hematopoietic stem cell and solid organ transplantation
Chairs: Medhat Askar (QA); Marcelo Cantarovich (CA)
The challenge of siloed program building vs. opportunities of integrationMarkus Selzner (CA)Immunologic bridgeRajdeep Das (US)One pathogen, two populationsMonica Slavin (AU)Beyond the graftTeun van Gelder (NL)Panel discussion on global perspectives on integration and innovationDiscussion Period (AU) -
16:45–18:00
Approaching and navigating difficult conversations with transplant patients
Chair: David Thomson (ZA)
Conversations around kidney transplant evaluation: Who and how to communicate non-eligibility for transplantRhiannon Reed (US)Palliative care post-transplant: Throughout patient journey and symptom managementKathryn Ducharlet (AU)Navigating through organ failure to transplant: Liver transplantSuk Kyun Hong (KR)Navigating conversations on cardiac mechanical support therapy to heart transplantShunichi Nakagawa (US) -
16:45–18:00
Poster Session 2
- 16:45–18:00 General topics
-
17:00–18:00
KDIGO Sponsored Symposium
This program is supported by an independent educational grant from Veloxis, an Asahi Kasei company
-
18:00–20:00
Networking Events
-
18:00–19:00
TSANZ Networking Event
Sponsored by
-
18:00–19:00
Mentee-Menor Networking Events
-
19:00–22:00
Congress Networking Event (ICC)
Wednesday, September 23, 2026
-
07:00–08:00
Biogen Corporate Breakfast Symposium on Advancements in Antibody-Mediated Rejection and Microvascular Inflammation of Kidney Allograft
Organized by
-
08:00–09:00
Morning Abstract and Concurrent Sessions
-
08:00–09:00
LMIC health system strengthening in transplantation: Improving access sustainably in Africa
Chair: David Thomson (ZA)
AFRAN: Who we are and what we offerIntissar Haddiya (MA)RwandaEmmanuel Muhawenimana (RW)EthiopiaMekdim Tadesse Siyoum (ET)NigeriaOlalekan Olatise (NG)Panel discussionDiscussion Period (AU) -
08:00–09:00
Basic mechanisms of experimental kidney allograft injury
Chairs: Shane Grey (AU); Anita Chong (US)
An AAV-Mediated Murine Model for the Study of ABO-Incompatible Kidney TransplantationJiang Zhang (CN)Mitochondrial injury in human and mouse kidneys with ischemia reperfusion injurySlaghaniya Neupane (CA)METTL3 Potentiates M2 Macrophage-Driven MMT to Aggravate Renal Allograft Fibrosis via the TGF-β1/Smad3 PathwayDajin Chen (CN)TLS-mediated B cell–SPP1⁺ macrophage–EndMT axis drives renal allograft fibrosis and its modulation by IguratimodLei Jiang (CN) -
08:00–09:00
Tolerance versus rejection 2
A novel depleting anti-CD2 monoclonal antibody for induction of mixed chimerism and allograft tolerance in nonhuman primatesAvery Wilson (US)Targeting the CXCL10–CXCR3 Axis Attenuates Macrophage Infiltration and Ameliorates Antibody-Mediated RejectionTian Wei (CN)NAMPT crotonylation dictates cardiomyocyte autophagy to modulate immune rejection in murine heart transplantationRuidong Ding (CN)TCF-1+ progenitor-like T cells sustain localized effector responses that mediate allograft rejectionFaruk Sacirbegovic (US)
-
08:00–09:00
Kidney allograft rejection; mechanisms and novel therapeutics
Chair: William Mulley (AU)
Subthreshold Inflammation Matters: A Continuum Model of TCMR RiskAravind Cherukuri (US)Microvascular Inflammation(MVI) In The Crosshairs: Do Allo- or Autoantibodies Shape Kidney Allograft Pathology?Vamsee Chirumamilla (US)Augmented washed microbiota transplantation for chronic allograft fibrosis in renal transplantationHongdi Cao (CN)Upregulation of cell death pathways in kidney rejectionXinyi Ding (AU) -
08:00–09:00
Insights into old and new therapeutics 2
Chair: Philip O'Connell (AU)
Preventing post-transplant squamous cell carcinoma: Q-2361 reverses tacrolimus-induced keratinocyte transformationJames Wells (AU)Cellular Senescence Drives Age-Related Resistance to Costimulatory Blockade in TransplantationSarah Tsou (US)Tacrolimus-resistant regulatory T cells in allotransplantationNaeem Abdul Ghafoor (GB) -
08:00–09:00
Key components of an ideal high volume transplant program setup: A global surgical perspective
Chairs: Dieter Broering (SA); Meng Qingze (CN)
The American perspectiveRobert A. Montgomery (US)The European perspectiveJiri Fronek (CZ)The Asian perspectiveAshwin Rammohan (IN)The Oceania perspectiveHenry Pleass (AU)Panel discussionDiscussion Period (AU) -
08:00–09:00
Metabolic dysfunction and liver transplantation
Chairs: Julie Heimbach (US); Geoffrey McCaughan (AU)
Obesity, diabetes and MAFLD- A target or bystander?Dinesh Jothimani (IN) -
08:00–09:00
Immune tolerance, biomarkers, and chronic allograft injury in liver transplantation
Chair: Nancy Kwan Man (HK)
ANXA1 and FPR signaling promotes immune tolerance by suppressing neutrophil extracellular traps after pediatric liver transplantationRuofan Wang (CN)Regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in adult live donor liver transplantationAngus Thomson (US)Liver-resident natural killer cells promote immune tolerance after liver transplantation via the PDL1/PD1 axis: Toward engineered cell therapyHaitao Huang (CN)Pretransplant natural killer cell activity predicts hpatocellular carcinoma recurrence and survival after living donor liver transplantationHo Joong Choi (KR)Integrative Transcriptomics and Machine Learning Identify Inflammatory and Profibrotic signalling as a Central Driver of Immune-Mediated Fibrosis in Chronic Liver Allograft Rejection.Marco Santillán Pazmiño (AR) -
08:00–09:00
Ethics and kidney transplantation
Chairs: Aviva Goldberg (CA); Ruben Omar Schiavelli (AR)
The role of comorbidities and insurance type in explaining intersectional racial and gender disparities in kidney transplant waitlisting: A mediation analysisAnnika Gompers (US)The kidney waiting list index (KiWI): Design and validation of the aotearoa New Zealand kidney transplant waiting list scoreHelen L. Pilmore (NZ)Residential Neighborhood Social Capital and Access to Live Donor Kidney TransplantationMara McAdams DeMarco (US)Economic evaluation of the Proposed Kidney Only Allocation Algorithm (KOALA) in AustraliaYitong Yao (AU) -
08:00–09:00
Advancing islet and stem cell transplantation: Immune modulation, bioengineering, and graft survival
Chairs: Hanne Scholz (NO); Angelika C. Gruessner (US)
A multi-centre study of Belatacept and Sirolimus for human islet transplantationNatasha Rogers (AU)The potential of Macaca fuscata, as a recipient model for porcine islet xenotransplantationNaoaki Sakata (JP)Subcutaneous cell sheet transplantation as a superior strategy to intraportal route for induced pluripotent stem cell-derived pancreatic islet cells therapyKoki Kurahashi (JP)Development of a Pre-vascularized Subcutaneous Site Using a Clinically Available Bioabsorbable Device for Islet TransplantationNorio Emoto (JP)Generation of ISL1-Overexpressing Islets with Enhanced Resistance to Apoptosis and Ferroptosis Improves Transplantation OutcomesYing Wang (CN)Immune cell and serum cytokine dynamics in islet transplant recipients receiving Belatacept/Sirolimus versus Tacrolimus/MycophenolateRachel Cheong (AU) -
08:00–09:30
CMV and BK virus in transplant recipients: Pearls from the guidelines and emerging frontiers
Chairs: Wanessa T. Clemente (BR); Jeremy Chapman (AU)
Pearls from the BK guidelinesNassim Kamar (FR)Pearls from the CMV guidelinesCamille N. Kotton (US)Beyond the guidelines- new developments and future directions: BKGermaine Wong (AU)Panel discussion: challenging BK case, challenging CMV caseDiscussion Period (AU) -
08:00–09:00
Pediatric general
Chair: Bethany J. Foster (CA)
Dysregulated succinate metabolism in M1 macrophages promotes hepatic stellate cell activation and graft fibrosis after pediatric liver transplantationZhixin Zhang (CN)Protective anti-HBs thresholds and risk of De Novo hepatitis B after pediatric liver transplantation using anti-HBc–positive donor graftsFigen Ozcay (TR)Pediatric organ donation after circulatory death in the United StatesMatthew Goldstein (US)Long-term outcomes of pediatric donation after circulatory death (DCD) liver transplantation: preliminary results from an European liver transplant registry studyFrancesca Albanesi (IT)Paediatric Lung Transplantation for Pulmonary Hypertension: Excellent Outcomes in a Nationally Centralised ProgramMiranda Paraskeva (AU)Measles-Mumps-Rubella vaccination after paediatric heart transplantationAnne Dipchand (CA) -
08:00–09:00
HLA, antibodies, and alloimmune risk in transplantation: Kidney-focused insights with cross-organ relevance
Chairs: Anne Halpin (CA); Refaat Kamel (EG)
Angiotensin II type I receptor antibodies are associated with retransplantation in liver allograftsJeyamani Ramachandran (AU)2026 Update of the Serologic Nomenclature for Factors of the HLA System; its impact in listing Unacceptable HLA antigens and DSA assessmentMarcelo Fernandez Viña (US)Impact of preformed donor specific antibodies on rejection, allograft survival and mortality in kidney transplant recipients: An Australian registry studyPaayal Naidu (AU)Evaluating the Impact of Shared Eplets on Cross-Reactivity in Single Antigen Bead Assays Using Customized HLA Bead PanelsDaiki Iwami (JP)Integrated HLA Epitope and PIRCHE-Based Modeling Improves Immunological Risk Stratification in Kidney TransplantationAhmed Mostafa (CA) -
08:00–09:00
Beyond static cold storage: Hypothermic machine perfusion in transplantation—from mechanisms to clinical impact
Chair: Sandra Lindstedt Ingemansson (SE)
Hypothermic oxygenated perfusion improves recipient survival in a rodent model of allogeneic intestinal transplantationKoki Takase (US)First experience with hypothermic oxygenated perfusion of human uteri: Feasibility and metabolic characterizationKeyue Sun (US)Real-World Use of Hypothermic Machine Perfusion: Trends and Impact on Short-Term Kidney Allograft OutcomesAlexander Cortez (US)Beyond static cold storage: active hypothermic lung preservation at 10°C using perfusion and CPAP in a porcine modelIrene bello (ES)Transplanting green kidneys in the era of machine perfusionGreta Gurry (AU) -
09:10–10:15
LMIC Health System Strengthening in Transplantation: Improving Access Sustainably in Pacific Asia
Vitalink: Who we are and what we offerCurie Ahn (KR)FijiAnis Ta'eed (FJ)VietnamThu Du (VN)PhilippinesRose Marie Rosete-Liquete (PH)
-
09:15–10:15
Abstract and Concurrent Sessions
-
09:15–10:15
ABO-incompatible kidney transplantation and antibody mediated rejection
Chairs: Kate Wyburn (AU); Peter Hughes (AU)
ABO-compatible kidney allocation with ABO-adjusted CPRAMichal Mankowski (US)ABO-incompatible kidney transplantation without desensitization - A German multicenter cohort studyMartina Koch (DE)Luminex mixed bead and single antigen bead assays have high positive percentage agreement for HLA-A, B and DR, with less agreement identified at HLA-DQPetrina Guthrie (AU)Clinical outcomes and prognostic factors of ABO-incompatible kidney transplantation: A single-center retrospective study using propensity score matchingMyung Yup Hyun (KR) -
09:15–10:15
Ischaemia reperfusion injury
Chair: Stephen Alexander (AU)
THBS1 Acts as an Intracellular "Brake" to Orchestrate Immune Remodeling and Mitigate Post-transplantation Liver InjuryBowen Wu (CN)RhoA/ROCK2/MYL9 signaling pathway mediates ischemia-reperfusion injury and fibrosis after liver transplantationZhixin Zhang (CN)IL-27Rα Deficiency Attenuates Renal Ischemia-Reperfusion Injury via Regulating Macrophage Polarization and Inhibiting Endoplasmic Reticulum StressYingqi Zeng (CN)PGE2 induces hypermethylation in MDSCs, thereby protecting against ischaemia-reperfusion injury in kidney transplantationXiaoyan Huang (CN)Translation study to document application of treprostinil for minimizing ischemia-reperfusion injury in donation after circulatory death livers using normothermic machine perfusionShambhavi Parab (US) -
09:15–10:15
Economics, environment and patient experience in kidney transplantation
Impact of different eplet matching strategies on the feasibility and equity of eplet based kidney allocationJames Lan (CA)Environmental performance of kidney replacement therapies: A comparative lifecycle assessmentChristopher Nguan (CA)The UAE Journey for Organ Transplantation: Evolution and Clinical Outcomes of a National and Pediatric Program (2017–2026)Abdalazeez Alghraizat (AE)Advancing deceased organ donation and transplantation in Dubai: A three-year analysis of system growth, clinical outcomes, and regional collaboration (2023–2025)HICHAM Aboualloul (AE)A Natural Experiment in Allocation: Outcomes of Mate Kidneys in Simultaneous Liver–Kidney Versus Kidney-Alone TransplantationOscar Garcia Valencia (US)Out-of-pocket expenditure and financial implications of renal transplant in children at a not-for-profit tertiary care hospital in a low-middle-income countryIndira Agarwal (IN)Patient perspectives on loneliness and social isolation in people receiving kidney replacement therapy including kidney transplant recipients: An interview study.Amanda Sluiter (AU)Survival of dialysis patients who declined kidney transplantation.Liliana Bisigniano (AR)
-
09:15–10:15
Immunoregulation in transplantation 2
Ex vivo Genetic Silencing of Donor MHC via Normothermic Machine Perfusion Achieves Long-term Renal Allograft SurvivalTong Chen (CN)IL4I1-I3P-AhR Axis-Mediated Tryptophan Metabolic Hijacking Orchestrates an mregDC-Treg Spatial Niche to Promote Allograft ToleranceZetao Ding (CN)CX3CR1+CD4+ cytotoxic T Cells target cholangiocyte self-antigens to drive autoimmunity in biliary atresiaWanglong Xiao (CN)Gut microbiota causally regulates allograft rejection through suppression of T helper 17 cell responsesYanzhuo Liu (CN)
-
09:15–10:15
Advances in organ preservation, perfusion, and peri-transplant monitoring across liver, kidney, and pancreas transplantation
Chair: Oscar Garcia Valencia (US)
Fingerprint in the cold: Perfusate profiling of extended criteria donor livers during hypothermic oxygenated perfusion using Raman spectroscopyMeryl Copray (NL)Sentinel skin flaps for monitoring of pancreas transplantsHelen Stark (GB)A four-component reconstruction planning in liver transplantation with 4d flow MRI validationBakhtiyar Kazymov (RU)Interim report on NEWHOPE: a first-in-human study on hypothermic machine perfusion with Omnisol preservation solution of deceased donor kidneys prior to transplantationLiselotte Jeletich (NL)Frequency and financial impact of DCD liver procurement dry runs in the normothermic machine perfusion eraAlexander Cortez (US)Ischemia-Free Liver Transplantation Reduces the Incidence of New-Onset Diabetes After TransplantationRuilin Cai (CN) -
09:15–10:15
From allorecognition to allocation: Moving toward more individualized kidney transplant matching
Chair: Rhonda Holdsworth (AU)
Importance of HLA beyond the A/B/DRAnat Tambur (US)Beyond HLA: Expanding the immunologic landscapeToby Coates (AU)Precision risk stratificationWai Lim (AU) -
09:15–10:15
Advancing equity and innovation in transplantation: From donor assessment to allocation and novel therapies
Timing and allocation trade-offs in liver transplantation for colorectal liver metastases: A decision-analytic studyQuirino Lai (IT)Toxoplasma gondii screening and seroprevalence in Australasian deceased organ donorsMadeleine Bangham (AU)Simultaneous transjugular intrahepatic portosystemic shunt and intraportal autologous mesenchymal stem cell infusion via a single access route in cirrhotic patients: A first-in-human proof-of-concept studySergey Astapovich (RU)Transplantation inequities among Hispanic and Latino Americans in the United States: A swim review with quantitative narrative synthesisGiuseppe Orlando (US)
-
09:15–10:15
Post-transplant complications, risk prediction & outcomes
Chair: Jiri Fronek (CZ)
Rate, Risk Factors and Outcomes of Early Hepatic Artery and Portal Vein Thrombosis After Pediatric Liver Transplantation: A 20-Year Review of a Large North American CenterBlayne Amir Sayed (CA)Incidence and Outcomes of Malignancy Following Adult Intestinal Transplantation: A National Cohort StudyNaeem Abdul Ghafoor (GB)Osteonecrosis After Liver Transplantation: The Role of Pre-transplant Disease Burden Beyond Corticosteroid ExposureEun Sung Jeong (KR) -
09:15–10:15
Immunosuppression in liver and kidney transplantation
Chairs: Jennifer Garcia (US); Roslyn B. Mannon (US)
CD40L-Target Nanoparticles Co-Delivering Sirolimus and CD28 siRNA for the Suppression of Allogeneic Liver Transplantation RejectionXiandong Zeng (CN)Imlifidase in highly sensitized kidney transplant recipients with a positive crossmatch against a deceased donor - Results of the French ISKIA RegistryLionel Couzi (FR)Encore presentation: The ConfIdeS study: Imlifidase desensitization results in timelier transplant with superior 1-year eGFR among highly sensitized patients compared to controlRobert A. Montgomery (US)Induction immunosuppression strategy and long-term graft and patient survival in contemporary adult liver transplantation: A United States allocation-era reassessmentIsabella Faria (US) -
09:15–10:15
Long-term outcomes and precision surveillance in heart transplantation: Rejection, vasculopathy, and immune monitoring
Chairs: Kavitha Muthiah (AU); Lori J. West (CA)
Heart transplantation during the War: Breaking barriers and exploring new frontiersBorys Todurov (UA)Cardiovascular Magnetic Resonance-Guided Rejection Surveillance in Cardiac Transplantation: Five-year Safety OutcomesYiling Situ (AU)The role of blood plasma cytokines in the diagnosis of rejection long-term after heart transplantationMaria Simonenko (RU)Progression of cardiac allograft vasculopathy in heart recipients with donor-transmitted coronary atherosclerosisStepan Sakhovsky (RU)Evaluation of the coronary arteries of a heart transplant using optical coherence tomographyStepan Sakhovsky (RU)HLA mismatch burden and De Novo malignancy after heart transplantation: A single-center Korean cohort studyDarae Kim (KR) -
09:15–10:15
Clinical outcomes, perioperative management, and organ utilization in transplantation
Chairs: Pranjal Modi (IN); Henry Pleass (AU)
Optimal timing of double J stent removal after kidney transplantation: a multicenter KQIPS cohort studySeung Jae Jason Kim (KR)Towards Outpatient Kidney Transplant: A Comparative Analysis of the AWAKE trial versus Standard Kidney TransplantationVinayak Rohan (US)‘Kidney-First’ Retrieval: A value enhancing approach to organ retrievalAkshay Kriplani (IN)Transplant renal artery stenosis: Validation for a new patho-anatomic classification with systematic review of the literatureAnimesh Singla (AU)Transplant renal artery stenosis: Proposal for a new patho-anatomic classification using intra-vascular ultrasound.Animesh Singla (AU)Lessons learned transplanting single pediatric kidneys into adult recipients - single center experienceAlex Zendel (US)Towards extended preservation of human livers during long-term normothermic machine perfusion: The role of bile acidsXuwenxuan Lucia Xie (AU)Donor In-Situ Ischemia Time: A Novel Modifiable Risk Factor for Early Graft Dysfunction in Kidney TransplantationPaul Robertson (AU)Comparative Assessment of Early Graft Injury Using Zero-Time Biopsy After Robotic Versus Open Kidney TransplantationMohammad Sherwani (IN)To preserve or to ligate? Surgical decision-making in multiple renal artery kidney transplantation: A meta-analysisFirtantyo Adi Syahputra (ID) -
09:15–10:15
Transplantation beyond traditional publications
Chairs: Stefan Tullius (US); Macey L. Levan (US)
Social media: Are we reaching our audience and readership worldwideJasper Iske (DE)Editorial fellowships: A great opportunity to be involvedMelanie Wyld (AU)Topic highlights – Article seriesCamille N. Kotton (US)Panel discussionDiscussion Period (AU)PanelistKhushboo Saxena (IN) -
09:15–10:15
Vascularized tissue engineering and organ-on-chip platforms for transplantation and organ replacement
Single-cell spatial mapping of immune microenvironments across the spectrum of skin rejection in vascularized composite allotransplantationSarah Short (GB)Toward Clinical Translation of NICHE: A Directly Vascularized Subcutaneous Platform with Local Immunomodulator Delivery for Pancreatic Islet Transplantation in Type 1 DiabetesAlessandro Grattoni (US)Application and Mechanism of Bionic Leaf Vein Chip in the Construction of Bioartificial KidneyZejiaxin Niu (CN)Functional Restoration of Apico-basal Polarity and Vascularization in Liver Organoids: A Highly Physiological Unit for Organ ReplacementMengyu Gao (CN)
-
10:15–10:45
Coffee Break / Last chance to visit Exhibit Area
-
10:15–10:45
Coffee Break
-
10:45–12:30
Plenary and Concurrent Sessions / TTS Business Meeting
- 10:45–12:00 Plenary Session 3
-
10:45–12:00
Expanding horizons in pancreas transplantation: Outcomes, techniques, and program development
Chairs: Pablo Uva (AR); Toby Coates (AU)
Current status of pancreas transplantation: Activity and outcomes around the worldAngelika C. Gruessner (US)Donation after circulatory death (DCD) in pancreas transplantation: Logistics, use of normothermic regional perfusion (NRP) and outcomesJoana Ferrer (ES)Future of pancreas transplantation in the landscape of emerging therapiesRaja Kandaswamy (US) -
12:00–12:30
TTS Business Meeting
-
12:30–13:45
Lunch Break / Industry Symposia / Lunch with Experts & Mentors
-
12:45–13:45
Industry Symposium
-
12:45–13:30
Lunch and Learn Roundtable
Combined liver–kidney transplantationGomathy Narasimhan (IN)Designing and strengthening organ donation systemsMarti Manyalich Vidal (ES)Genetic factors influencing transplant outcomesStephen Alexander (AU)Clinical Trials in Kidney TransplantationSteve Chadban (AU)From HLA typing to epitope matchingLucy Sullivan (AU)Encouraging physical activity in transplant recipients with limited endurance or physical limitationsLiz Schick (CH)Roundtable MentorRoslyn B. Mannon (US)Roundtable MentorGermaine Wong (AU)Roundtable MentorKate Wyburn (AU)Roundtable MentorMedhat Askar (QA)Roundtable MentorMacey L. Levan (US)Roundtable MentorHenry Pleass (AU)TBD related to Uterus Transplant (ethics or donor/recipient selection or pregnancy challenge, etc)Mats Brännström (SE)Multi-Organ transplantation in childrenTomoaki Kato (US)
-
13:45–15:15
SOTA, Thematic and Concurrent Sessions
-
13:45–15:15
Clinical Xenotransplantation has Arrived!
Chairs: Richard N. Pierson (US); Robert A. Montgomery (US)
Understanding optimal genetic modificationPeter Cowan (AU)Experience and immunosuppression for clinical xenotransplantationMuhammad Mohiuddin (US)Molecular analysis in clinical xenotransplantationCarmen Lefaucheur (FR) -
13:45–15:15
Living Organ Donation in 2026: Unified Principles, Organ-Specific Nuances
Chairs: Kwang Woong Lee (KR); Henry Pleass (AU)
Shared framework for living donor evaluation: medical, psychosocial, and ethical coreKrista Lentine (US)Surgical challenges and functional outcomes in living kidney donationMireia Musquera (ES)Surgical challenges and functional outcomes in living liver donationDongJin Joo (KR)Predictive models and global registry insights to enhance donor safetyAllan Massie (US) -
13:45–15:15
Targeted Therapies and Tailored Dosing: The New Era in ABMR Treatment
Chair: Jen Li (AU)
Is there still a role for anti IL-6R in ABMR treatment?Roslyn B. Mannon (US)Is anti-CD38 the most promising agent for ABMR?Katharina Mayer (AT)What does monitoring AUC add compared to C-trough only?Teun van Gelder (NL)Model Informed precision dosingAnders Asberg (NO) -
13:45–15:15
Pediatric cholestatic liver disease around the world
Chairs: Gabriel E. Gondolesi (US); Manuel Rodriguez-Davalos (US)
Biliary atresia - whats happening in Latin America. Access to KPE and transplantationMonserrat Arreola Gutierrez (MX)Alagille syndrome - past, present and futureSusan Mei-Ling Siew (AU)Progressive familiar intrahepatic cholestasis differences around the world and the role of medical vs. surgical therapyMohamed Rela (IN)Primary sclerosing cholangiotis in children and adolescentMichael Stormon (AU) -
13:45–15:15
Diversity, Equity, and Inclusion in Gender and Transplantation
Chairs: Maria Gomez (AE); Victorine Bandolo Nzana (CM)
Regional and gender disparities in abstracts presented at international transplant congressMaggie Kam Man Ma (HK)Unseen and unequal: Addressing gender and financial disparities in access to kidney transplantationNicole Jane Scholes-Robertson (AU)Redefining equity: Women, access, and outcomes in liver transplantationGomathy Narasimhan (IN) -
13:45–15:15
Evolving Ethics and Emerging Trends in Transplantation
Chairs: David Thomson (ZA); Aviva Goldberg (CA)
Rating ourselves on the ethics of NRP - How are we doing?Anji Wall (US)Social media use in transplantationShaifali Sandal (CA)Pediatric prioritizationThozama Siyotula (ZA)Retransplantation after nonadherence (adult & children)Aaron Wightman (US) -
13:45–15:15
Innovations in skin cancer in transplantation
Chairs: Angela Webster (AU); Brenda Maria Rosales (AU)
Skin cancer risk prediction and communicationAnne Cust (AU)Complex surgical oncologyAlexander Varey (AU)Novel developments in keratinocyte cancer treatments in AustraliaKiarash Khosrotehrani (AU)Panel DiscussionDiscussion Period (AU) -
13:45–15:15
Rise of the Machines: Maximizing donor opportunities in Thoracic Transplantation
Chairs: Miranda Paraskeva (AU); Pablo Sanchez (US)
Debate 1: Pro normothermic regional perfusionAshish S. Shah (US)Debate 1: Pro ex vivo machine perfusionPeter MacDonald (AU)Debate 2: Pro ex vivo perfusionSandra Lindstedt Ingemansson (SE)Debate 2: Pro immediate transplantGregory I. Snell (AU)Expanding the donor pool: Practical implementation of normothermic regional perfusion for DCD heart and lung recoveryIrene Bello Rodriguez (ES)Panel DiscussionDiscussion Period (AU) -
13:45–15:15
State of VCA- Present and Future
Chairs: Patrik Lassus (FI); Hatem Amer (US)
Overview of VCA transplantsHatem Amer (US)VCA becoming part of universal health careDavid Leonard (GB)Is VCA reconstructive surgery or transplantationLinda C. Cendales (US)Challenges and opportunities for VCA in the global southSubramania Iyer (IN)Standardizing outcomes in VCA: Are we ready for a SONG or for COVERAllison Jaure (AU) -
13:45–15:15
Next-Generation Transplantation: Regenerative Medicine Breakthroughs
Chair: Giuseppe Orlando (US)
The bioartificial kidney: Lessons learned and the road aheadWilliam Fissell (CA)Organoids, organs-on-a-chip, and the path to organ manufacturingSean Vincent Murphy (US)Artificial heart: A life-saving bridge to transplantFrancisco Arabia (US) -
13:45–15:15
Evolving strategies in intestinal and multivisceral transplantation
Chairs: Helen Evans (NZ); Rajith Amaratunga (AU)
Isolated intestine transplantation for short gut syndrome in the era of GLP-2 agonistYaron Avitzur (CA)Novel immunosuppression in intestine transplantationJennifer Garcia (US)Pros and cons of protocol biopsy and stomaJonathan Hind (AU) -
13:45–15:15
Organ donation following MAID (VAD/euthanasia)
Chairs: Peggy John (CA); Helen Opdam (AU)
Canadian donation perspectiveMatthew Weiss (CA)Australian donation perspectiveWade Stedman (AU)New Zealand donation perspectiveKim Grayson (NZ) -
15:20–16:30
Closing Plenary
-
15:20–16:30
Closing Plenary
Chair: Nadey Hakim (GB)
Gene and cell therapy in transplantationMaria Grazia Roncarolo (US)